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Foreword 
Innovation and technological development are crucial for economic growth and development 
and for the competitiveness of industries. Evidence shows that technical progress and 
innovation lead to a more efficient use of labour and capital inputs, and thus foster 
productivity, one of the main drivers of growth in most OECD countries for more than two 
decades.  
World regions and countries are competing to attract and retain those segments of global 
value chains that contribute most to value and job creation. In a context of increasing 
globalisation and interdependence of knowledge generation and its exploitation, policies 
aiming at reinforcing the scientific and technological competitiveness of economies need to 
rely on a wide range of science, technology and innovation indicators reflecting increasingly 
complex innovation systems.  
A main actor in innovation systems is the business sector. Evidence shows that a very large 
proportion of the R&D investments financed and executed by the business sector worldwide 
is concentrated in a relatively small number of world-leading corporate innovators, in many 
cases large multinational groups. These companies also account for a significant proportion 
of the patents and trademarks filed in the most important intellectual property offices around 
the world.  
In this respect, the original data and statistics on the innovation output of the world's top 
corporate R&D investors presented in this report are extremely relevant for the support of 
evidence-based research and innovation policies. The report builds on the efforts to collect 
up-to-date, reliable and comparable company data on the top corporate R&D investors 
worldwide carried out by the European Commission since 2004 (the EU Industrial R&D 
Investment Scoreboard publication) and on the solid knowledge and experience of the OECD 
in developing and providing robust and state-of-the-art indicators on science, technology and 
industry (see for example OECD's STI Scoreboard publications). 
Essentially descriptive in nature, the company-based data and statistics on the patents and 
trademarks portfolios of the world's top corporate investors open the door to further research 
into, and analysis of, companies' global strategies for knowledge development and 
exploitation.   
The main target audience of this report is the policy and research community, as well as 
analysts with an interest in supporting evidence-based policy making in the area of 
innovation and industrial policies. The underlying company data on patents and trademarks 
will be made publicly available. The objective is to allow practitioners to make intensive use 
of these data to contribute to the advancement of knowledge and empirical evidence on 
companies' innovative activities and performance.  
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Director  
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Director 
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Executive Summary 
 
This report looks at the innovative output of world’s top Research and Development (R&D) 
investors using patents and trademarks as proxy indicators. Essentially descriptive in nature, 
the study presents statistics about the patent portfolio of companies, and their trademark 
strategies to launch new products, and looks at the extent to which companies bundle these 
two forms of Intellectual Property Rights (IPR) to protect and appropriate the returns of their 
knowledge-based assets. The newly constructed dataset provides interesting insights about 
the innovation strategies of the world’s leading corporate R&D investors.  
 
 
The patent portfolio of top corporate R&D investors  
Patenting activities highlight heterogeneous industry and firm-specific behaviours 
Top corporate R&D investors show a high degree of heterogeneity in their propensity to 
patent. The structural features of the industry in which companies operate are a relevant 
determinant, but not the only one, as important differences also emerge across companies 
operating in the same industry. The highest propensity to patent is shown by companies 
operating in the ‘Electrical equipment’ industry, and the lowest by companies operating in the 
‘Pharmaceuticals’ industry. 
Patent applications are concentrated in a narrow set of technologies 
Overall, the world top corporate R&D investors considered in this report, accounting for over 
90% of global business R&D spending, own 66% of all patent families covering five large IP 
offices worldwide (IP5). 
The patenting activity of these companies focuses mostly on technologies related to 
Electrical engineering (accounting for almost half of total patent families) and Mechanical 
engineering (accounting for one-fifth of the total). Over the last 10 years, the greatest 
increases in patent filings have been in the fields of Computer technology and Electrical 
machinery (the two most represented technological fields). In general, patent filings related to 
Information and Communication Technologies (ICT) have increased while the share 
accounted for by technologies such as Organic chemistry and Pharmaceuticals has been 
declining. 
Of the top 10 patenting companies in the sample, nine are headquartered in Asia, and eight 
belong to the ICT sector. Overall, their patent portfolio accounts for one-quarter of the total 
patents owned by the top R&D investors.   
The technological concentration of patent portfolios varies widely across industries. 
Companies with a higher industrial diversification master a wider range of technologies. 
Technological diversification also relates to the geographical diversification of the 
companies’ subsidiary structure, but to a much lesser extent. Among the four industries 
accounting for the highest number of top R&D investors, ‘Machinery’ displays the highest 
technological diversification. Companies operating in the ‘Computers & electronics’ industry 
also master a relatively wide array of technologies, while companies in the ‘Pharmaceuticals’ 
industry show a much narrower specialisation profile. 
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Top corporate R&D investors pursue distinct filings strategies across Intellectual 
Property (IP) offices and over time 
The distribution of IP5 patent families reflects the changes in the global innovation and 
economic landscape of the last decade. The current picture is more balanced, reflecting the 
rapid increases in filings at the Korean and Chinese international patent offices.  
Key indicators used to proxy the technological and economic value of patents show that, 
compared with European Patent Office (EPO) filings, applications at the Unites States Patent 
and Trademark Office (USPTO) are of smaller family size, fact which might reflect the 
attractiveness of the US market vis-à-vis other markets. At the same time, these patent 
families exhibit higher radicalness but lower average technological scope.  
Top corporate R&D investors differentiate their filing strategies across the IP5 offices 
depending upon the technological field of the invention to protect. Patent families filed at the 
Korean Intellectual Property Office (KIPO), the USPTO and the SIPO (the State Intellectual 
Property Office of the People’s Republic of China) are largely oriented towards Electrical 
engineering applications, whereas EPO patent family members show a stronger orientation 
towards Mechanical engineering and Chemistry. Patent family members at the Japan Patent 
Office (JPO) are the most oriented towards Instruments, and also account for the second 
highest share in the field of Mechanical engineering.  
The geographical distribution of technological advantages reveals a wider specialisation 
of European and US-based companies 
Top corporate R&D investors located in Europe and the United States are relatively more 
specialised in a wider array of technologies, including those that are fundamental to address 
grand challenges such as health, ageing and the environment. Companies based in Korea, 
China and Japan show a high degree of specialisation in ICT-related technologies, whereas 
Europe-based companies show lower revealed technological advantages. Japan-based 
companies appear to specialise in a wider array of technologies than those in Korea or China.  
Top corporate R&D investors rely on international knowledge to develop their 
technologies 
About one-quarter of companies’ patent portfolios have been developed by teams of 
inventors residing in countries that are different from the location of the headquarters. For 
companies operating in ‘Mining’, ‘Finance & insurance’ and ‘Pharmaceuticals’ industries, 
international patents account for more than half of their portfolios. 
The trademarks portfolio of top corporate R&D investors worldwide  
The geographical distribution of trademark (TM) applications is largely driven by the 
location of company headquarters 
Trademark applications mirror the location of company headquarters, with most of them in 
the United States, Japan, Germany, the United Kingdom and France. Top corporate R&D 
investors tend to be more active at USPTO than at the Office for Harmonization in the 
Internal Market (OHIM). The office with the highest home specificity is JPO: more than 
three-quarters of applications to JPO come from companies headquartered in Japan. At the IP 
Australia, levels of trademarking activities are low, but top R&D investors from Switzerland 
are particularly active in that office. 
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Trademark applications are concentrated in a few classes and a few products fields 
Most trademark applications made by top corporate R&D investors relate to goods alone or to 
goods and services jointly and most are filed in the Instruments and computers and the 
Pharmaceutical products classes. Services-related trademarks pertain mainly to R&D and 
software. Trademark applications related to knowledge assets come from a small number of 
countries featuring developed and competitive markets for research. Companies tend to 
deploy consistent international trademark strategies across classes. Top corporate R&D 
investors from China and Korea exhibit a strong orientation towards ICT and audiovisuals-
related trademarks.  
Trademark applications feature salient industry specificities 
Significant industry specificities emerge with respect to the use of trademarks, trademark 
intensity (i.e. number of trademarks per euro of net sales) and concentration ratios. The 
‘Pharmaceuticals’, ‘Chemicals’, ‘Food products’, ‘Electrical equipment’ and ‘Textiles’ 
industries appear as very active in trademarking. Companies operating in ‘Computers & 
electronics’, conversely, exhibit relatively low levels of trademarking activity at the offices 
considered. ‘Pharmaceuticals’ and ‘Computers & electronics’ appear as the most ‘diversified’ 
industries, as they own trademarks registered in a variety of good and services classes.   
The adoption of common word mark strategies in international markets remains 
limited  
Trademarks signal the uniqueness of goods and services through the use of signs as words, 
images, sounds or any combination of these. While word marks constitute the most common 
type of mark applied for by top corporate R&D investors, only a low share of identical word 
marks is protected across the different offices. In addition, top corporate R&D investors seem 
more likely to adopt close trademarking strategies in the European and the US markets. 
The IP bundle: the combined use of patents and trademarks  
Top corporate R&D investors use patents and trademarks as complementary protection 
means 
The combined use of patents and trademarks (IP bundle) is favoured by the majority of 
companies in the US and European markets. Alternative means of protection (or no 
protection) are more frequently used at JPO, where Japan-based companies predominate in 
terms of overall IP filings. Companies operating in the ‘Chemicals’, ‘Pharmaceuticals’, ‘Food 
products’, ‘Computers & electronics’ and ‘Other manufactures’ industries are more likely to 
combine the two IP rights analysed. Services-oriented companies operating in the ‘IT 
services’ and ‘Finance & insurance’ industries tend to protect their assets primarily through 
trademarks. All-in-all, patents remain the most commonly used means of protection at 
USPTO, EPO/OHIM and JPO. Industries with low patent propensities (e.g. ‘Food products’ 
and ‘Pharmaceuticals’) tend to have more trademark applications.  
The joint commonality of patent families and word marks is industry specific 
Top corporate R&D investors file more frequently patents related to the same technical 
invention than word marks related to the use of identical word(s) in different offices. The 
‘Textiles & apparel’ industry represents an exception to this trend. In the case of applications 
at USPTO and OHIM by companies in the ‘Pharmaceuticals’ and ‘Food products’ industries, 
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common patents account for a large proportion (about one-half) while identical words in 
trademarks are much less frequent (less than 15%). Conversely, industries with the lowest 
shares of common patents (e.g. ‘Computers & electronics’ and ‘Textiles & apparel’) are more 
likely to employ the very same word in their trademark applications at these two offices.  
Few product fields relate to a wide range of patented technologies  
Top corporate R&D investors operating in a broad range of technological areas mainly 
trademark products related to Instruments and computers and/or Pharmaceutical products. 
Trademarks related to R&D and software are owned by companies with very different 
technological backgrounds. Few companies present technology/product combinations in line 
with the profile of the industry in which they operate. The ‘Pharmaceuticals’ industry shows 
the strongest uniformity, with more than half of its companies featuring an IP portfolio 
mainly composed of patents in Pharmaceuticals and trademarks in Pharmaceutical products. 
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1. Innovation output: looking at the other side of R&D investment  
 
Over the last decades, many important policy initiatives put in place worldwide (such as 
the European Union’s strategy for jobs and growth, Europe 20201) aimed at fostering 
innovation and technological development by increasing R&D spending and shifting the 
balance between public and private investment in R&D.  
These supply-push policies are motivated by the expectation that higher R&D spending - 
in particular larger R&D spending by the business sector - would lead to more technological 
development, innovation, competitiveness and eventually more and higher quality jobs.  
To what extent do businesses turn investment in R&D into new technologies, improved 
processes or new products launched on global markets? The long standing tradition of 
measuring R&D spending by businesses has generally not been paralleled by a similar wealth 
of statistics on the innovation output generated by such R&D spending.  
This report addresses this vacuum by looking at the patent and trademark-related 
activities of the top 2000 corporate R&D investors worldwide. In 2012, these companies 
accounted for EUR 539 billion total annual R&D investment, corresponding to more than 
90% of the total business R&D expenditure of OECD countries plus Argentina, China, 
Romania, the Russian Federation, Singapore, South Africa, and Chinese Taipei. Top 
corporate R&D investors own 66% of all IP5 patent families worldwide and account for an 
average 8% of 2012 trademark applications at the USPTO, the JPO, the OHIM and IP 
Australia (respectively 6%, 16%, 11% and 7%).   
Patents are legal instruments used to protect inventions
2
 developed by firms, institutions 
or individuals. Patents give owners the right to exclude others from making, using, selling, 
offering for sale or importing the patented invention for the term of the patent. This is usually 
20 years from the filing date of the application, and the right exists only for the country or 
countries designated for protection.  
Patent data have, for more than half a century, been used to proxy innovation output (see 
for example, Pavitt, 1985, and Acs and Audretsch, 1989, and Griliches, 1990, for early 
surveys); whereas trademark-related data have been used more recently to proxy non-R&D 
based innovations and innovation in services, and have been found to relate to innovative and 
marketing activities (see Millot, 2012, and Squicciarini et al., 2012, for overviews).
3
 
This report is essentially descriptive in nature and develops indicators of: i) the 
technological profiles of top corporate R&D investors; ii) the areas in which they trademark 
their (new) products and processes; and iii) the extent to which top corporate R&D investors 
worldwide rely on the IP ‘bundle’, i.e. on more than one IPR type at the same time, to protect 
their knowledge-based assets and better appropriate the returns from their innovation-related 
investment.  
Accordingly, the report is structured in four key sections, as follows.  
                                                 
1
 See http://www.consilium.europa.eu/ueDocs/cms_Data/docs/pressData/en/ec/115346.pdf 
2
 Article 28 of the Trade-Related Intellectual Property Rights [TRIPS] Agreement. 
3
 A thorough discussion of the pros and cons of using such innovation proxies, which is out of the scope of the 
present report, can be found in the studies mentioned above, as well as in the literature that followed.  
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Section 2 describes the dataset developed for this analysis, and in particular the linking of 
patent and trademark data from key IP offices to the data of the top 2000 corporate R&D 
investors worldwide. 
Section 3 looks at the patent portfolios of these top corporate R&D investors and provides 
information about the technology fields in which patent protection is sought, the 
technological breadth and radicalness of those patents, as well as the patent protection 
strategies that such companies pursue worldwide and their geographical scope. It also 
investigates industry specificities in companies’ propensity to patent. 
Likewise, section 4 describes the trademark portfolios of the top 2000 corporate R&D 
investors, including those companies’ propensity to rely on trademarks, as well as the goods 
and/or services classes in which protection is sought. Furthermore, industry-specific 
differences in trademark strategies pursued by the top corporate R&D investors are 
investigated. A final sub-section looks at the extent to which these corporations pursue 
similar marketing and positioning strategies in different markets. To this end, an experimental 
approach is devised to exploit information about trademarks consisting solely (or mainly) of 
words - here termed ‘word marks’ - and investigate the extent to which the very same word 
marks are protected at different intellectual property offices.  
Section 5 concludes by shedding some light on the extent to which top corporate R&D 
investors worldwide rely on the joint use of patents and trademarks to protect the knowledge-
based assets they generate.
4
   
  
                                                 
4
 In OECD (2013) industrial designs are included in the definition of the IP bundle. The same cannot be done in 
the present study due to data limitations.  
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2 The data 
2.1 The corporate structure and location of top R&D investors 
The analysis presented in this report is based on the sample of the top 2000 corporate 
R&D investors worldwide published in the 2013 edition of the EU Industrial R&D 
Scoreboard,
5
 which features the ranking of the companies that invested the most, i.e. the 
largest sums, in R&D in the year 2012.  
These companies are either parents of (a number of) subsidiaries and participated, or are 
independent companies. In the former case, the R&D spending figure considered for the 
ranking is the one that appears in their consolidated accounts,
6
 and that includes the spending 
made by their subsidiaries. Overall, the top R&D investors considered in the present study 
had more than 500,000 ‘controlled’ subsidiaries (defined as firms owned for more than 50% 
by the parent)
7
 in 2012.  
As patents and trademarks can be applied for by parent companies and/or by any of their 
subsidiaries, the figures presented in the remainder of this report have been compiled based 
on patent and trademark data mirroring the IP activity of the top 2000 R&D investors as well 
as their ‘controlled’ subsidiaries8 during the period 2010-12. The corporate structure of the 
top 2000 R&D investors worldwide used for this purpose is the one resulting at the end of 
2012.  
This conservative choice, and the consequent focus on a relatively short period of time, is 
driven by lack of information about the pre-2012 corporate structure of top R&D performers. 
This makes it impossible to accurately map the intellectual property-related activities of top 
corporate R&D performers over time, and the extent to which company dynamics such as 
mergers, acquisitions and divestment might have shaped patent and trademark stock and 
flows.   
As a matter of fact, it might be reasonable to hold that the corporate structure of top R&D 
performers over the two years preceding 2012, i.e. 2010-11 was sufficiently similar to that 
observed in 2012,
9
 and that statistics based on this three-year period should provide a 
substantially accurate picture of their IP-related activities. Conversely, the same might not be 
true if longer time frames were to be considered.
10
 
Figure 2.1a shows the geographic distribution of the headquarters of the 2000 top 
corporate R&D investors considered in this report. In 2012, more than 60% of these 
companies (i.e. 1247) were headquartered in four countries, namely the United States, Japan, 
                                                 
5
 Report available at: http://iri.jrc.ec.europa.eu/scoreboard13.html. 
6
 For more information on the EU R&D Scoreboard data and methodology, refer to the report, in particular to its 
Annex 2 – Methodological notes. 
7
 This includes "branches", which account for about 34% of all subsidiaries. 
8
 Despite the efforts made to try and fully map the group structure of the companies considered, the existence of 
other controlled affiliates cannot be fully ruled out. While there is no reason to think that this bias, if it exists, 
would systematically affect only one or some of the industries considered, omitting to account for the patent and 
trademark activities of these (at present) unknown affiliates might nevertheless lead to underestimated statistics.  
9
 During the period considered, i.e. 2010-2012, countries also differed with respect to their position in the 
business cycle, as most OECD economies were still in recession, while other countries continued to growth. 
This might also have shaped corporate dynamics and innovative activities in a way that, in any case, cannot be 
assesses. 
10
 This is true even if most part of top corporate R&D performers persistently show among top R&D investors 
worldwide. 
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Germany and the United Kingdom, and about 9% (i.e. 175 companies) in China and Chinese 
Taipei. 
Figure 2.1a - Location of the world top R&D investors’ headquarters, 2012 
 
Source: IPTS-OECD, calculations based on EU R&D Scoreboard data, 2013. Map source: ARCTIQUE© - All rights reserved. 
While headquarters are concentrated in a relatively small set of countries, the affiliates of 
top corporate R&D investors appear spread across 202 economies around the globe, as can be 
seen from Figure 2.1b. Despite their seemingly ubiquitous location, though, more than 60% 
of these affiliates are located in four countries, i.e. the United States, Japan, France and the 
United Kingdom. 
Figure 2.1b - Location of the world top R&D investors’ subsidiaries, 2012 
  Source: IPTS-OECD, calculations based on EU R&D Scoreboard data, 2013. Map source: ARCTIQUE© - All rights reserved. 
Figure 2.2a details the extent to which top corporate R&D investors worldwide are 
headquartered in Europe, and shows that, in general, Eastern European member countries do 
not see the presence of such headquarters. 
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2.2a Location of the world top R&D investors, headquarters, European Union, 2012 
 
  Source: IPTS-OECD, calculations based on EU R&D Scoreboard data, 2013. Map source: ARCTIQUE© - All rights reserved. 
The picture changes by the time the location of the affiliates of top corporate R&D 
investors headquartered in the European Union is considered. As can be seen from Figure 
2.2b, top R&D investors headquartered in Europe have affiliates located worldwide, and 
importantly so in Eastern European countries, North America and Brazil, as well as Russia 
and Australia.  
Figure 2.2b – Subsidiaries’ location of the European’s top R&D investors, 2012 
  Source: IPTS-OECD, calculations based on EU R&D Scoreboard data, 2013. Map source: ARCTIQUE© - All rights reserved. 
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Figure 2.3 shows the extent to which the top 2000 R&D investors worldwide diversify their 
subsidiaries’ structure, in terms of both geographical location and industrial activities of their 
affiliates. The statistics are shown according to the main industry of activity of the 
headquarters, and are ranked according to the average number of countries covered.  
Figure 2.3 – Diversification of subsidiaries of the top world R&D investors, 2012 
a) Geographical location of subsidiaries, number of countries in the corporate structure  
 
 
 
b) Industry classifications of subsidiaries, number of industries in the corporate structure, ISIC, rev.4 
 
Note: Data relate to industries companies with at least 10 companies in the top 2000 corporate R&D sample. The industry 
classification used refers to an aggregation of the NACE, rev. 2 list into 38 industries.  
Source: IPTS-OECD, calculations based on EU R&D Scoreboard data, 2013. 
Although some industries are the most (or least) diversified over both dimensions 
considered, heterogeneous strategies emerge, as rankings differ across the geographical and 
industrial dimensions.  
‘Transport services’ is the relatively most diversified industry both geographically and at 
the industry level, whereas ‘Scientific R&D’ lies at the other extreme of the spectrum. While 
some industries show a level of diversification persistently above or below the average on 
both dimensions (e.g. ‘Computers & electronics’ and ‘Pharmaceuticals’, two of the most 
represented industries in terms of top R&D investors), others exhibit divergent patterns. For 
example, firms in the ‘Construction’ industry appear industrially diversified but 
geographically concentrated.  
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Figure 2.4 – Distribution of subsidiaries by geographical location, 2012 
Share of subsidiaries across economic areas 
 
Note: the x axis shows the location of the headquarters. 
Source: IPTS-OECD, calculations based on EU R&D Scoreboard data, 2013. 
Figure 2.4 provides further insights about the geographical location of the affiliates and 
participated of top corporate R&D performers, vis-à-vis the location of the headquarters.  The 
data suggest that top corporate R&D performers seemingly concentrate their subsidiaries
11
 in 
the very same area where the headquarters are located. Organisational and market-related 
strategies, as well as the attempt to minimise organisation and communication-related costs 
might contribute to explain the patterns observed.  
Japan’s top corporate R&D investors show the highest share of national subsidiaries 
(79%), whereas in the case of US investors only 59% of their subsidiaries are located at 
home. An important number of US top corporate R&D investors’ affiliates can also be found 
in Europe (27%), whereas European companies show a relatively smaller share of 
subsidiaries located in the United States than their American counterparts (16%).  
China and Korea exhibit similar and high proportions of national subsidiaries (around 
65%), but differ in the extent to which they penetrate other key markets: Korean companies 
have similar percentages of subsidiaries in Europe and the United States (around 13%), 
whereas Chinese companies are particularly present in Europe (17% as compared to about 
6% in the United States). Finally, companies headquartered in the rest of the world appear to 
have the highest share of subsidiaries located in Europe (about one half) and an important 
percentage in the United States (about 20%), whereas their presence in key Asian countries is 
almost negligible (about or below 1% in the case of Japan, China and Korea). 
2.2 Linking company data to IP data: a matching approach 
Characterising the IP portfolio of companies requires IPR data to be linked with 
enterprise data. To this end, the names of the top corporate R&D investors and of their 
subsidiaries have been matched to the applicants’ names provided in patent and trademark 
documents (see also 2.3 and 2.4). The linking has been carried out on a by-country basis 
                                                 
11
 The term 'subsidiaries' is used in order to refer to any type of affiliates or participated companies included in 
the present study. 
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using a series of algorithms contained in the Imalinker system (Idener Multi Algorithm 
Linker) developed for the OECD by IDENER, Seville, 2013.  
The matching exercise carried out is implemented over a number of key steps: 
• The names of top corporate R&D investors and subsidiaries and of the firms 
included in the IPR-related data are separately harmonised using country-specific 
‘dictionaries’. These aim at dealing with legal entities’ denomination (e.g. ‘Limited’ and 
‘Ltd’), common names and expressions, as well as phonetic and linguistic rules, which 
may affect how enterprise names are written. Failing to account for such features of the 
data might mistakenly lead to exclude, e.g. not consider a company only because its 
name has been misspelt or shortened in some places, or double count the same company 
as its misspelled name makes it look like different entities. The compilation of suitable 
country- and language-specific dictionaries requires country level and language-related 
knowledge. 
• In a second step, a series of string-matching algorithms – mainly token-based and 
string-metric-based, like token frequency matching, Levenshtein (1965) and Jaro-
Winkler (Winkler, 1999) distances – are used to compare the harmonised names from the 
two datasets and provides a matching accuracy score for each pair. The precision of the 
match, which depends on minimising the number of false positive matches, is ensured 
through a selection of pairs of company names / IPR owners made on the basis of high-
score thresholds imposed on the algorithm.  
• A post processing stage is handled manually and requires reviewing the results of 
the matches; assessing the proportion of non-matched patenting firms (possibly false 
negatives, i.e. firms that the algorithm failed to recognise as part of the sample) within 
the top R&D performers and affiliates; and identifying new matches on a case-by-case 
basis (e.g. allowing for lower thresholds for a given algorithm), by correcting and 
augmenting dictionaries and through manual searches. 
The matching was performed using the names of both the top corporate R&D investors 
and their subsidiaries. IP portfolios have then been aggregated at the level of the 
headquarters: patents and trademarks owned by a given subsidiary are thus fully attributed to 
the mother company of the group.
12
  
Overall, 97% of top R&D-performing companies could be matched to at least one patent 
applicant, either directly or through one or more subsidiary firms. The same overall matching 
rate is observed for trademark applications.  
Table 2.1 and Table 2.2 report the matching rates obtained at the level of the 
companies/groups and the share of matched subsidiary firms, according to the location of the 
parent company.   
As can be seen, matching rates vary across the economies in which the top corporate 
R&D investors are located, and are seemingly affected by factors such as the structure of the 
group, the extent to which subsidiaries are accounted for, and the location of the affiliates.   
The extent to which subsidiary firms could be paired with IP data is shown in table 2.2. 
Typically, the matching scores observed for subsidiary firms are lower than those observed 
                                                 
12
 This is regardless of the precise structure of the group. In practical terms, this choice implies that the patents 
and trademarks of a certain subsidiary are attributed to the mother R&D performer under all circumstances, and 
independently of the exact share of the affiliate that the mother company owns (whether e.g. 60% or 70%).  
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for their headquarters, in the case of both patents and trademarks. This suggests that while 
basically all top corporate R&D performers worldwide do directly own an IP portfolio, the 
same cannot be said for their subsidiaries. In addition, IPR portfolios appear to be distributed 
in an uneven fashion across countries and industries, thus signalling the existence of market-
specific and activity-specific strategies and behaviours, as will become clearer later.   
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Table 2.1 - Linking top 2000 R&D performers to IP data,  
matching scores at the level of the companies, by companies’ headquarter location 
 
Source: IPTS-OECD, calculations based on EU R&D Scoreboard data, 2013; the Worldwide Patent Statistical Database, EPO, 
December 2014; and OECD Trademark database (internal), 2014. 
  
Top 2000 
R&D Performers
Companies Companies % Companies %
Australia 15 14 93.3 15 100.0
Austria 12 12 100.0 12 100.0
Belgium 13 13 100.0 13 100.0
Bermuda 10 9 90.0 8 80.0
Brazil 8 8 100.0 8 100.0
Canada 17 17 100.0 17 100.0
Cayman Islands 49 38 77.6 35 71.4
China 98 94 95.9 73 74.5
Chinese Taipei 82 82 100.0 76 92.7
Curaçao 1 1 100.0 1 100.0
Czech Republic 1 1 100.0 1 100.0
Denmark 25 24 96.0 25 100.0
Finland 20 20 100.0 20 100.0
France 75 72 96.0 75 100.0
Germany 130 125 96.2 130 100.0
Greece 1 0 0.0 1 100.0
Hungary 1 1 100.0 1 100.0
Iceland 1 1 100.0 1 100.0
India 22 20 90.9 20 90.9
Ireland 11 11 100.0 11 100.0
Israel 15 15 100.0 15 100.0
Italy 30 29 96.7 30 100.0
Japan 353 351 99.4 351 99.4
Korea 56 56 100.0 55 98.2
Liechtenstein 1 1 100.0 1 100.0
Luxembourg 4 3 75.0 3 75.0
Malaysia 1 1 100.0 1 100.0
Malta 1 0 0.0 1 100.0
Mexico 1 1 100.0 1 100.0
Netherlands 34 32 94.1 34 100.0
New  Zealand 2 2 100.0 2 100.0
Norw ay 11 10 90.9 11 100.0
Portugal 4 4 100.0 4 100.0
Russian Federation 4 4 100.0 3 75.0
Saudi Arabia 1 1 100.0 1 100.0
Singapore 5 4 80.0 5 100.0
Slovenia 1 1 100.0 1 100.0
South Africa 1 1 100.0 1 100.0
Spain 16 16 100.0 16 100.0
Sw eden 40 38 95.0 38 95.0
Sw itzerland 54 54 100.0 54 100.0
Thailand 1 1 100.0 1 100.0
Turkey 6 2 33.3 4 66.7
United Kingdom 106 94 88.7 102 96.2
United States 658 649 98.6 656 99.7
Venezuela 1 1 100.0 1 100.0
Virgin Islands (British) 1 1 100.0 1 100.0
Matched to 
patent applicants
Matched to 
trademark applicants
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Table 2.2 - Linking top 2000 R&D performers to IP data,  
matching scores at the level of the subsidiaries, by companies’ headquarter location 
 
Note:  The data are broken down according to the location of the R&D company, wherever the location of the subsidiary firms.  
Source: IPTS-OECD, calculations based on EU R&D Scoreboard data, 2013; the Worldwide Patent Statistical Database, EPO, 
December 2014; and OECD Trademark database (internal), 2014. 
 
 
Top 2000 
R&D Performers
Subsidiaries Subsidiaries % Subsidiaries %
Australia 2 664  511 19.2  735 27.6
Austria 1 764  350 19.8  306 17.3
Belgium 6 425  739 11.5 1 917 29.8
Bermuda  378  62 16.4  52 13.8
Brazil 1 798 1 037 57.7  476 26.5
Canada 2 457  447 18.2  690 28.1
Cayman Islands  872  84 9.6  70 8.0
China 3 159  461 14.6  190 6.0
Chinese Taipei 3 271  597 18.3  389 11.9
Curaçao  702  449 64.0  359 51.1
Czech Republic  285  13 4.6  1 0.4
Denmark 3 106  706 22.7  790 25.4
Finland 3 783  550 14.5  581 15.4
France 85 029 27 939 32.9 25 954 30.5
Germany 49 983 10 092 20.2 10 939 21.9
Greece  22  0 0.0  0 0.0
Hungary  107  4 3.7  1 0.9
Iceland  57  16 28.1  5 8.8
India 1 756  293 16.7  350 19.9
Ireland 3 094  780 25.2  886 28.6
Israel 1 354  214 15.8  248 18.3
Italy 10 124 1 002 9.9 1 882 18.6
Japan 92 423 25 142 27.2 30 820 33.3
Korea 2 778 1 161 41.8  950 34.2
Liechtenstein  803  121 15.1  253 31.5
Luxembourg 1 744  280 16.1  166 9.5
Malaysia  469  4 0.9  11 2.3
Malta  39  0 0.0  3 7.7
Mexico 2 283  223 9.8  391 17.1
Netherlands 12 444 2 521 20.3 3 522 28.3
New  Zealand  89  8 9.0  10 11.2
Norw ay 1 757  144 8.2  118 6.7
Portugal  907  9 1.0  50 5.5
Russian Federation 3 883  49 1.3  10 0.3
Saudi Arabia  210  74 35.2  7 3.3
Singapore  266  67 25.2  53 19.9
Slovenia  29  1 3.4  1 3.4
South Africa  64  20 31.3  15 23.4
Spain 14 558 4 686 32.2 6 451 44.3
Sw eden 9 572 1 398 14.6 1 307 13.7
Sw itzerland 13 700 3 837 28.0 3 237 23.6
Thailand  38  3 7.9  1 2.6
Turkey  140  3 2.1  4 2.9
United Kingdom 52 036 15 207 29.2 15 450 29.7
United States 116 434 50 780 43.6 48 908 42.0
Venezuela  23  1 4.3  1 4.3
Virgin Islands (British)  7  0 0.0  0 0.0
Matched to 
patent applicants
Matched to 
trademark applicants
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2.3 Innovative output: patent data  
To better reflect the inventive activity that top corporate R&D performers carry out 
worldwide, the statistics presented here are based on patent applications filed at the five top 
IP offices (IP5) in the world: EPO, JPO, KIPO, SIPO and USPTO.
13
  
Depending on a number of factors and on the market strategies that companies pursue, 
innovators may want to protect the very same invention in different countries. This being the 
case, they need to file a set of related patent applications in each national or regional office 
where protection is sought. Consequently, the first patent filing made to protect a given 
invention worldwide (the so-called ‘priority’ filing) is often followed by (a series of) 
subsequent and related filings, thus giving birth to a so-called patent ‘family’ (see Martínez, 
2011, for a discussion).  
To avoid counting several times those patents that have been filed at different IP offices 
with the aim to protect the very same invention, patent portfolios hence need to be 
consolidated on the basis of the families that patents belong to.  
The notion of patent families considered in this study follows the ‘extended’ family 
definition, in which patent applications are directly or indirectly linked through the priority 
filings. The scope of extended patent families is broader than that of mere patent 
‘equivalents’, i.e. patents filed at different IP offices claiming the exact same priority patent, 
as  patents in the same family encompass the incremental steps that may have followed an 
original invention. The definition also accounts for sets of patents filed at a given IP office 
(e.g. JPO) that may have been recombined into a single patent application filed at another IP 
office (e.g. EPO). Consequently, patent families do not reflect here single and unique 
inventions, but groups of inventions. This might, to some extent, lead to underestimate the 
possible incremental innovative steps that companies might take in relation to other, prior or 
more important, inventions. In any event, such a choice should not affect the present analysis, 
as R&D projects are generally heterogeneous in aim and in the size of the funding involved, 
and there is no ex-ante reason to believe that systematic biases exist. Moreover, as companies 
generally do not disclose information on the nature and the timing of their research projects, 
it is difficult to try and precisely link R&D inputs to patent output other than using a time-
based criterion (i.e. their assumed simultaneity, based on evidence such as Hall et al., 1986) 
and information about possible priority and patent family documents. 
Three alternative definitions have been proposed in this respect. Going from definition 1 
to definition 3, the filing requirements for patents to be taken into account become 
progressively stricter. In this way it is possible to define distinct subsets of comparatively 
more valuable patents, in terms of families they belong to:   
 Definition 1: Families of patent applications with members filed at one or more IP5 
offices, including single filings. This implies that applications filed only in one of 
the IP5 offices, i.e. EPO, USPTO, JPO, KIPO and SIPO, are taken into account.  
 Definition 2: Families of patent applications with members filed at least in one of the 
IP5, excluding single filings. This implies that applications filed only in one of the 
                                                 
13
 The five IP offices (IP5) is a forum of the five largest intellectual property offices in the world that was set up 
to improve the efficiency of the examination process for patents worldwide. The IP5 Offices together handle 
about 80 per cent of the world's patent applications, and 95 per cent of all work carried out under the Patent 
Cooperation Treaty (PCT), see http://www.fiveipoffices.org/. 
 World Corporate Top R&D Investors: Innovation and IP bundles 
 
21 
IP5 offices, i.e. EPO, JPO, KIPO, SIPO and USPTO, are considered only in so far as 
another family member has been filed in any other office worldwide (anywhere in 
the world, not necessarily at another IP5 office). 
 Definition 3: This is the most restrictive definition, as families of patent applications 
are considered only in so far as family members have been filed in at least two IP5 
offices. For instance, patents filed at USPTO will be considered only if an equivalent 
filing has been made in any of the remaining IP5 offices. This is irrespective of 
whether equivalent applications in non-IP5 offices also exist. 
No rank or order exists with respect to the IP5 offices, and all are considered to be 
equally important.  
As shown in figure 2.5, the inclusion of single filings in Definition 1 (patents filed only 
once worldwide) introduces country biases: companies located in Japan tend to apply for a 
large proportion of patents in their home IP office only, with single filings at JPO that 
represented 70% of patent families originating from Japanese companies in 2010-12. This 
phenomenon is even more pronounced for Chinese companies, which seemingly tend to 
protect their inventions on their own market, with 93% of patent families from Chinese 
companies consisting of single filings.  
Figure 2.5 - Patent filing routes by companies’ headquarter location, 2010-12 
Distribution of patent families with at least one member in one of the IP5 offices, including single filings (Definition 1) 
 
Note: Data relate to economies with at least 100 patent families filed by the top corporate R&D investors worldwide in 2010-12. 
Source: IPTS-OECD, calculations based on EU R&D Scoreboard data, 2013; and the Worldwide Patent Statistical Database, 
EPO, December 2014. 
As it rules out singletons, i.e. single filings, from the family definition, Definition 2 
provides a more balanced picture of the patenting activity of top R&D performers, and helps 
to shed light on their strategic behaviour. By imposing a higher threshold, whereby only 
patent families with members in at least two of the IP5 offices are considered, counts of 
patent families relying on Definition 3 further help to reflect the relative value of inventions 
made by those companies. On average, it is observed that 85% of patent families owned by 
the top R&D performers cover patents filed at two or more of the IP5 offices. The proportion 
varies with the location of the companies' headquarters considered in the current sample. 
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Figure 2.6 - Portfolio of patent families by companies’ headquarter location, 2010-12  
Alternative family definitions 
 
Source: IPTS-OECD, calculations based on EU R&D Scoreboard data, 2013; and the Worldwide Patent Statistical Database, 
EPO, December 2014. 
Definitions 2 and 3 are highly correlated, as shown in figure 2.6 and table 2.3. Table 2.3, 
in particular, uses data about the patent portfolio of top corporate R&D investors over the 
period 2010-12 to show the correlation between the different definitions considered (left-
hand side of the table) and the Spearman’s rank correlation (right-hand side of the table). The 
latter provides information about the extent to which the positioning of the top R&D 
investors changes depending on the specific patent family definition considered.  
The correlations shown suggest that using Definition 2 instead of Definition 1 to omit 
inventions of relatively lower importance or value (i.e. the singletons) from the analysis 
would lead to somewhat different results (with a simple correlation value of 0.858 and a 
Spearman’s rank correlation value of 0.862). Conversely relying either on Definition 2 or 
Definition 3 would basically lead to very similar results (as correlation values are .993 
and .983 in the case of simple and rank correlations, respectively).  
In an attempt to be as encompassing as possible when accounting for the innovation 
output of top corporate R&D investors and to construct indicators related to inventions of 
‘comparable’ technological and economic value, in what follows the analysis will be based 
on the less restrictive of the internationally comparable measures proposed, i.e. Definition 2.  
Table 2.3 - Correlation of value and rank between definitions, 2010-12 
 
Source: IPTS-OECD, calculations based on EU R&D Scoreboard data, 2013; and the Worldwide Patent Statistical Database, 
EPO, December 2014. 
Table 2.4 presents the top 50 patenting companies ranked on the basis of their patent 
portfolios, defined according to Definition 2. The importance of Asia in this respect can be 
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Number of patent families
Axis in logarithmic scale
Def. 1 Def. 2 Def.3 Def. 1 Def. 2 Def.3
Def. 1 1.000 0.858 0.862 1.000 0.836 0.823
Def. 2 0.858 1.000 0.993 0.836 1.000 0.983
Def. 3 0.862 0.993 1.000 0.823 0.983 1.000
Correlation Spearman's rank correlation
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immediately seen. Of the top ten patenting companies, nine are headquartered in Asia, eight 
belong to the ICT sector, and account for 25% of all the patents owned by these investors. 
More precisely, Samsung Electronics (Korea) ranks first, owning almost 5% of the patent 
portfolio of the top 2000 R&D investors worldwide; other large Asian companies operating 
in the ‘Electronics’ and ICT industries follow in the ranking. Notably, 22 top performers are 
Japanese companies, whereas only 9 US-headquartered top R&D investors and 6 European 
ones make it in the top 50 list.   
As could be expected from the correlation figures shown above, the ranking of top R&D 
investors in terms of patenting activity over the period considered is basically identical when 
Definitions 2 and 3 are considered. With the exception of three companies, namely 
Volkswagen AG, Blackberry Limited and Sei Investments Company, the same corporate 
R&D investors persistently rank among the top 50, irrespective of the patent family definition 
used.  
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Table 2.4 - Top 50 patenting companies, 2010-12 
Top 50 patenting companies according to Definition 2 and shares of their patent portfolio in the total top R&D performers' one, 
comparison with the ranking obtained using Definition 3 in the last columns. 
 
Source: IPTS-OECD, calculations based on EU R&D Scoreboard data, 2013; and the Worldwide Patent Statistical Database, 
EPO, December 2014. 
Figure 2.7 gives a flavour of the age distribution of the patent portfolios currently owned 
by the top corporate R&D investors, i.e. according to the year in which patents were first 
filed. The statistics are shown by industry of the headquarters; the age is based on the earliest 
filing date of any patent family member. The latest year for which patent applications are 
Share Rank Share Rank Diff.
Samsung Electronics Co.,Ltd. KR 4.7 (1) 5.4 (1)
Hon Hai Precision Industry Co., Ltd. TW 3.0 (2) 2.3 (5) +3
Toshiba Corporation JP 2.8 (3) 3.1 (3)
Canon Inc. JP 2.8 (4) 3.1 (2) -2
Panasonic Corporation JP 2.3 (5) 2.5 (4) -1
Sony Corporation JP 2.0 (6) 2.3 (6)
Hitachi Ltd. JP 1.9 (7) 2.1 (7)
General Electric Company US 1.9 (8) 2.1 (9) +1
Fujitsu Limited JP 1.9 (9) 2.1 (8) -1
Foxconn Technology Co., Ltd. TW 1.7 (10) 1.8 (10)
Fujifilm Holdings Corp. JP 1.6 (11) 1.7 (11)
Robert Bosch GMBH DE 1.4 (12) 1.1 (19) +7
LG Corp. KR 1.4 (13) 1.6 (12) -1
Toyota Motor Corporation JP 1.3 (14) 1.4 (13) -1
Siemens AG DE 1.2 (15) 1.1 (18) +3
General Motors Company US 1.2 (16) 1.2 (15) -1
Seiko Epson Corporation JP 1.2 (17) 1.3 (14) -3
Samsung Display Co.,Ltd. KR 1.1 (18) 1.2 (16) -2
Ricoh Co., Ltd. JP 1.1 (19) 1.2 (17) -2
Denso Corporation JP 1.0 (20) 1.0 (22) +2
Dow Chemical Company (The) US 1.0 (21) 0.9 (26) +5
LG Electronics Inc. KR 0.9 (22) 1.0 (20) -2
International Business Machines Corp. US 0.9 (23) 0.8 (29) +6
Samsung Electro-Mechanics Co.,Ltd. KR 0.9 (24) 1.0 (21) -3
Mitsubishi Electric Corporation JP 0.9 (25) 0.9 (24) -1
Honda Motor Co., Ltd. JP 0.8 (26) 0.9 (25) -1
Huawei Technologies Co., Ltd. CN 0.8 (27) 0.9 (23) -4
Mitsumi Electric Co., Ltd. JP 0.8 (28) 0.8 (27) -1
Microsoft Corp. US 0.7 (29) 0.8 (28) -1
Sharp Corporation JP 0.7 (30) 0.7 (32) +2
Hyundai Motor Company Co.,Ltd. KR 0.7 (31) 0.8 (30) -1
Brother Industries Ltd. JP 0.7 (32) 0.7 (31) -1
Qualcomm Inc. US 0.7 (33) 0.6 (36) +3
SK Hynix Inc. KR 0.6 (34) 0.7 (33) -1
Kyocera Corporation JP 0.6 (35) 0.7 (35)
Telefonaktiebolaget LM Ericsson SE 0.6 (36) 0.7 (34) -2
United Technologies Corporation US 0.6 (37) 0.6 (38) +1
European Aeronautic Defence and Space Company Eads N.V. NL 0.5 (38) 0.5 (44) +6
Volkswagen AG DE 0.5 (39) 0.4 (55) +16
Sumitomo Electric Industries, Ltd. JP 0.5 (40) 0.6 (40)
NEC Corporation JP 0.5 (41) 0.6 (37) -4
Koninklijke Philips N.V. NL 0.5 (42) 0.6 (39) -3
Taiwan Semiconductor Manufacturing Company Limited TW 0.5 (43) 0.5 (42) -1
Blackberry Limited CA 0.5 (44) 0.3 (65) +21
Olympus Corp. JP 0.5 (45) 0.6 (41) -4
Sei Investments Company US 0.5 (46) 0.4 (57) +11
Sumitomo Chemical Company Limited JP 0.5 (47) 0.4 (51) +4
Samsung SDI Co.,Ltd. KR 0.5 (48) 0.5 (43) -5
Honeywell International Inc. US 0.4 (49) 0.5 (45) -4
Renesas Electronics Corporation JP 0.4 (50) 0.4 (47) -3
Definition 2 Definition 3
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available is 2012, as patent documents are typically made public (i.e. published) 18 months 
after the filing date, and there is an additional delay for the information to be integrated and 
processed in the EPO’s Worldwide Patent Statistical Database that is released twice a year 
(this analysis relies on the most recent version, i.e. the December 2014 version).  
The average age of top corporate R&D investors’ patent portfolio is of about 9 years, 
with industry-specific median and average values that are generally very similar. Conversely, 
differences across industries emerge, with the patent portfolios of top corporate R&D 
investors in the ‘Telecommunications’ and ‘Pharmaceuticals’ industries seemingly being, on 
average, among the oldest. ‘Law, accountancy & engineering’, ‘Computer & electronics’ and 
‘Publishing & broadcasting’ are the industries that own the youngest portfolios (average 
filing date in 2004).  
Figure 2.7 - Age of companies' patent portfolio by industry, ISIC, rev.4, 1992-2012 
Statistical distribution, based on patent families’ first filing dates 
 
Note: Data relate to industries with at least 100 patent families.   
Source: IPTS-OECD, calculations based on EU R&D Scoreboard data, 2013; and the Worldwide Patent Statistical Database, 
EPO, December 2014. 
 
2.4. Innovative output: trademark data  
This section provides an overview of the trademark applications of the top corporate 
R&D investors across four IP offices worldwide: the USPTO,
14
 the OHIM, the Australian 
Intellectual Property Office (IP AUS) and the JPO. The USPTO, JPO and IP AUS are 
national offices, whereas the OHIM administers the Community Trade Marks (CTMs), i.e. 
trademarks that are valid throughout the European Community and that coexist with 
nationally granted trademarks.
15
 
Figure 2.8 shows the number of trademark applications filed by the top corporate R&D 
investors worldwide by IP office and location of the headquarters. IP offices are ranked 
                                                 
14
 For more details on USPTO trademark data, see Graham et al. (2013).  
15
 For more details, see http://oami.europa.eu/ohimportal/en/.  
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according to the total number of TM applications received in the period 2010-12.
16
 The 
overall level of TM applications received by the different offices may reflect, among other 
factors, the size and attractiveness of the markets that countries represent and the strategies 
that companies pursue in different markets, and can be influenced by the specific design of 
trademark systems (e.g. validity of trademarks linked to proving the actual use of such IPR). 
In the case of OHIM, the coexistence of national trademark systems may further shape the 
extent to which the system is used.  
Figure 2.8 - Trademark applications by office and companies’ headquarter location, 2010-12 
 
Note: Trademark counts are based on the application date, the address of the applicant’s headquarters and fractional counts. 
*Data for JPO are up to May 2012. 
Source: IPTS-OECD, calculations based on EU R&D Scoreboard data 2013 and OECD Trademark database (internal) 2014.
17
 
At USPTO, JPO and OHIM most TM applications come from companies with 
headquarters located in the same country as the office. This is particularly marked for JPO, 
where more than 80% of top R&D investors’ applications come from companies with 
headquarters located in Japan. In contrast, residents’ applications tend to be less preponderant 
at IP AUS, where more than two-thirds of trademark applications come from companies 
headquartered in the United States and the EU-28 Member States.  
The importance of trademarking activities by non-resident companies may reflect the 
degree of market penetration by foreign firms. In addition to the factors mentioned above, it 
may also be influenced by factors such as institutional relationships and commercial 
agreements between countries and regions. 
Table 2.5 lists the top trademark applicants among the top corporate R&D investors and 
shows the shares of applications they account for, and their ranking in terms of total 
trademark applications, at each of the offices considered. The 44 companies listed are those 
that rank among the top 50 applicants in at least two of the four offices considered.  
 
                                                 
16
 Figures for the JPO only include applications up to May 2012. 
17 
The OECD Trademark database (internal), 2014 refers to trademark data from various sources, namely: US 
Patent and Trademark Office Bulk Downloads: Trademark Application Text hosted by Reed Technology 
Information Services, OHIM Community Trademark Database CTM Download, April 2014, JPO Trademark 
Data, September 2012 and IP Australia Trademarks Data, April 2013. 
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Table 2.5 – Top trademarking companies, 2010-12 
Share of companies in trademark applications filed by the top 2000 R&D performers and relative ranking, by office 
 
Note: Trademark shares and ranks are calculated based on the total applications filed by the top 2000 R&D investors in each 
office in 2010-12, using fractional counts. The industry classification used refers to an aggregation of the NACE, rev. 2 list into 
38 industries. Companies in each subgroup of the table are listed in alphabetical order. 
Source: IPTS-OECD, calculations based on EU R&D Scoreboard data, 2013; and OECD Trademark database (internal), 2014. 
The picture that emerges is one that differs substantially from the one observed in the 
case of patent ownership. ICT companies play an important role in terms of both trademark 
and patent activities. In contrast, R&D investors operating in the ‘Pharmaceuticals’ and 
‘Chemicals’ industries systematically appear among the top companies only when 
considering trademarking activities. 
Also, companies’ ranking tends to differ widely across offices. Only four companies are 
persistantly ranked among the top 50 applicants across the four offices. This suggests that 
companies pursue different TM strategies in the various markets. Different patterns may also 
be observed at the industry level. The ranking of companies in the ‘Pharmaceuticals’, 
‘Computers & electronics’ and ‘Chemicals’ industries suggests a similar trademarking 
Share Rank Share Rank Share Rank Share Rank
JOHNSON & JOHNSON US Pharmaceuticals 2.1% 2 1.5% 5 0.8% 29 1.1% 10
LG ELECTRONICS KR Computers & electronics 1.0% 9 2.0% 1 0.5% 49 2.0% 2
SONY JP Computers & electronics 0.9% 10 1.1% 10 0.9% 22 0.7% 30
TAKEDA PHARMACEUTICAL JP Pharmaceuticals 0.6% 24 0.6% 17 0.8% 25 0.8% 21
ABBOTT LABORATORIES US Pharmaceuticals 0.4% 36 0.4% 44 0.2% 99 0.5% 39
BASF DE Chemicals 0.4% 49 0.6% 19 0.1% 235 0.9% 17
BAYER DE Pharmaceuticals 0.6% 20 0.7% 14 0.3% 82 0.8% 23
DIAGEO GB Food products 0.5% 27 0.5% 22 0.1% 230 0.4% 49
GLAXOSMITHKLINE GB Pharmaceuticals 1.4% 4 0.5% 30 0.5% 55 2.2% 1
HENKEL DE Chemicals 0.4% 33 0.5% 21 0.0% 357 0.4% 45
JARDEN US Electrical equipment 1.3% 7 0.5% 25 0.2% 104 0.5% 41
L'OREAL FR Chemicals 0.6% 19 1.9% 3 0.3% 79 1.7% 4
LVMH FR Textiles & apparel 0.5% 28 0.4% 34 0.1% 234 1.1% 11
MERCK US US Pharmaceuticals 0.6% 22 0.4% 45 0.1% 243 0.5% 35
NESTLE CH Food products 0.9% 11 0.5% 31 0.0% 561 1.5% 5
NISSAN MOTOR JP Transport equipment 0.4% 40 0.4% 35 0.7% 37 0.0% 563
NOVARTIS CH Pharmaceuticals 1.3% 6 2.0% 2 0.3% 73 1.8% 3
PFIZER US Pharmaceuticals 0.8% 13 0.5% 26 0.6% 41 0.2% 133
PROCTER & GAMBLE US Chemicals 1.4% 3 1.7% 4 0.4% 59 1.0% 14
RECKITT BENCKISER GB Chemicals 0.5% 30 1.3% 7 0.1% 250 1.0% 13
SAMSUNG ELECTRONICS KR Computers & electronics 0.7% 16 0.7% 15 0.1% 152 0.9% 15
SIEMENS DE Computers & electronics 0.4% 32 0.7% 16 0.0% 383 0.9% 19
ASAHI BREWERIES JP Food products 0.1% 385 0.0% 648 1.2% 14 0.5% 36
BALLY TECHNOLOGIES US Arts & entertainment 0.8% 12 0.0% 1322 0.0% 903 0.9% 18
BOEHRINGER INGELHEIM DE Pharmaceuticals 0.6% 21 0.2% 130 0.1% 185 1.2% 7
COLGATE-PALMOLIVE US Chemicals 0.4% 44 0.4% 49 0.0% 322 0.1% 274
DAIMLER DE Transport equipment 0.3% 65 0.4% 39 0.1% 195 0.4% 42
DOW CHEMICAL US Chemicals 0.4% 46 0.4% 41 0.2% 122 0.0% 378
ELI LILLY US Pharmaceuticals 0.7% 15 0.7% 13 0.3% 67 0.1% 229
FUJIFILM JP Computers & electronics 0.1% 167 0.2% 98 0.7% 35 0.4% 43
GENERAL ELECTRIC US Machinery 0.5% 26 0.5% 29 0.2% 120 0.4% 58
HASBRO US Other manufactures 0.7% 14 0.4% 38 0.1% 200 0.0% 1054
HEWLETT-PACKARD US Computers & electronics 0.4% 31 0.4% 43 0.2% 126 0.0% 818
HUAWEI CN Computers & electronics 0.4% 48 0.9% 12 0.1% 272 0.2% 142
ILLINOIS TOOL WORKS US Machinery 0.3% 62 0.5% 33 0.1% 251 0.7% 25
INTERNATIONAL GAME TECHNOLOGY US Other manufactures 0.6% 23 0.2% 126 0.0% 902 1.1% 8
KIRIN JP Food products 0.1% 335 0.0% 584 0.7% 33 0.9% 20
MERCK DE DE Pharmaceuticals 0.3% 59 0.6% 18 0.1% 242 0.7% 24
MONDELEZ US Food products 0.4% 34 0.3% 54 0.2% 136 0.8% 22
NINTENDO JP Other manufactures 0.2% 90 0.4% 40 1.2% 15 0.3% 89
SANOFI-AVENTIS FR Pharmaceuticals 0.7% 17 0.2% 129 0.2% 111 1.1% 9
SEI INVESTMENTS US Finance & insurance 0.6% 18 0.5% 28 0.1% 256 0.4% 60
SYNGENTA CH Chemicals 0.4% 50 0.3% 78 0.0% 562 0.6% 34
VOLKSWAGEN DE Transport equipment 0.3% 76 1.1% 8 0.0% 438 0.9% 16
In the top 50 of the 4 offices
In the top 50 of 3 offices
In the top 50 of 2 offices
USPTO OHIM JPO IP AUS
Company name Country Industry
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behaviour across different offices, whereas companies from other industries, for instance 
‘Food products’, seemingly behave in a different way in different markets. This may depend 
on factors such as the possibility or need to standardise products or, conversely, the need to 
differentiate products and services according to the market targeted.   
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3. The patent portfolio of top corporate R&D investors 
Key findings 
 Patenting activities highlight heterogeneous industry and firm-specific behaviours 
 Patent applications are concentrated around a narrow set of technologies 
 Top corporate R&D investors pursue distinct filings strategies across IP offices and over time 
 The geographical distribution of technological advantages reveals a wider specialisation of 
European and US-based companies 
 Top corporate R&D investors rely on international knowledge to develop their technologies 
 
The rationale behind patent systems is to solve a problem of knowledge appropriability. 
To this end, ex ante guarantees to provide ex post exclusionary rights (and thus monopoly 
rents) are offered to inventors as an incentive to invest in discovery and development. This is 
done in exchange for supply of the invention to society and disclosure of the technical 
information related to it, in a manner that can be understood by qualified third parties. By 
providing information about new knowledge, patents may foster the diffusion of information 
that might otherwise be kept secret, and enable subsequent inventions (see e.g. Scotchmer, 
2004). 
Patent-based indicators, exploiting information contained in patent filings, convey 
information on the output and processes of the underlying inventive activities. Patents protect 
inventions and, although the relationship is not a simple one, research has shown that when 
the proper controls are applied, there is a positive relationship between patent counts and 
other indicators related to innovation and economic performance (productivity, market share, 
etc.). This relationship varies across countries, industries and over time. Indeed, before an 
invention can become an innovation, further entrepreneurial efforts are required to develop, 
manufacture and market it.   
The statistical exploitation of the data contained in patent documents offers unique 
insights into invention processes. Among others, patents provide information on the 
technological content of inventions (i.e. their technical domain), the geographical location of 
the inventive process, and who contributed to develop the inventions. They help tracking the 
technological development and positioning of given entities in technology fields and areas 
(e.g. indexes of revealed technological advantages), and their evolution over time. Finally, 
because patents identify owners and inventors, they may also provide useful information 
about the organisation of the underlying research process. 
The data on the patent portfolio of top corporate R&D investors analysed in this section 
result from the methodology described in section 2.3. The analysis intends to cover different 
dimensions of companies' patenting behaviours and strategies, using state of the art indicators 
related to patent propensity, technological focus and concentration, patent value and 
international patterns.   
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3.1 Propensity to patent: stylised facts 
The propensity to patent aims to capture the extent to which innovative efforts, measured 
in terms of R&D investment, translate into innovative output, as proxied by patents. This 
indicator is defined as the number of patents obtained per R&D euro (or dollar) spent 
(Scherer, 1983).  Evidence suggests that the propensity to patent varies across industries, 
countries and over time, and is shaped by a number of factors, including framework 
conditions such as market structure and regulations (see for example, Mansfield, 1984; Acs 
and Audretsch, 1989).   
Figure 3.1 shows the patent propensity of the top corporate R&D investors worldwide for 
the period 2010-12, as measured by the number of patent families filed per million Euros 
(M€) invested in R&D. ‘Pharmaceuticals’ companies emerge as those with the lowest 
propensity to patent, as these companies obtain, on average, only 0.03 patent families for 
each million Euros invested in R&D. At the other end of the distribution, ‘Electrical 
equipment’ companies obtain 0.52 patent families per million Euros invested in R&D, thus 
exhibiting a patent propensity which is more than 17 times that of pharmaceutical companies. 
Such differences might be driven by some structural features of the industries considered, the 
degree of complexity and modularity of the products they produce, as well as differences in 
their strategic and competitive behaviours (see Somaya, 2012, for a review). 
 
Figure 3.1 – Patent propensity of the Top R&D investors by industry, ISIC rev. 4, 2010-12  
Number of patent families per M€ R&D investment 
 
 
Note: Data relate to industries with at least 20 companies in the top 2000 corporate R&D investors sample.  
Source: IPTS-OECD, calculations based on EU R&D Scoreboard data, 2013; and the Worldwide Patent Statistical Database, 
EPO, December 2014.  
In the case of ‘Electrical equipment' companies, the figures shown imply that an average 
R&D investment of about 2 M€ is required per patent family. Companies operating in the 
‘Machinery’ industry show a similar, albeit slightly lower, propensity to patent, and are 
followed by corporate investors in the ‘Computer & electronics’, ‘Wood & paper’, ‘Basic 
metal’, ‘Rubber, plastic, minerals’, and ‘Chemicals’ industries. All the other industries show 
patent propensities below the 0.22 value of the sample average, corresponding to an R&D 
investment of about 4.5 M€ per patent family. In the case of ‘Pharmaceuticals’, this 
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investment is, on average, of 32 M€ per patent family.  
In the same way as the propensity to patent varies across industries, important differences 
also exist between firms operating in the same industry. Figure 3.2 illustrates the extent to 
which the propensity to patent varies within industries, by showing the industry-specific 
coefficients of variation, which represent a standardised measure of variability.
18
   
Figure 3.2 –Variation in the patent propensity, by industry of top R&D investors, ISIC rev. 4, 2010-12 
Coefficient of variation by industry 
 
 
Source: IPTS-OECD, calculations based on EU R&D Scoreboard data, 2013; and the Worldwide Patent Statistical Database, 
EPO, December 2014. 
A marked heterogeneity in the patent propensity of firms belonging to the same industry 
emerges, as well as a somewhat negative correlation between the propensity to patent at the 
industry level and the coefficient of variation within the industry: generally, the larger the 
average number of patents obtained for a certain amount of R&D investment at the industry 
level, the smaller the difference in the extent to which within-industry firm-specific 
propensities to patent vary.  
Among the industries with relatively higher patents to R&D ratios, ‘Computers & 
electronics’ is the only industry that shows a high variability in the propensity to patent. 
Conversely, ‘Electrical equipment’ and ‘Machinery’, the top two industries in terms of 
propensity to patent, are among the industries featuring the lowest within variability.    
3.2 A patent-based technological profile 
3.2.1 The technological focus of top corporate R&D investors  
Patent data allow identifying the main technological fields in which top corporate R&D 
investors focus their inventive activities. Information about the technology classes in which 
patents are filed can in fact be used as a proxy for technological specialisation (e.g. Patel and 
Pavitt, 1997), and thus identify the technological competences at the basis of companies’ 
output and performance.  
                                                 
18
 The coefficient of variation is defined as the ratio of the standard deviation to the mean. It is a measure of 
variability relative to the mean of a given population and allows for meaningful comparisons between 
populations showing different averages. 
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To this end, the concordance between International Patent Classification (IPC) and   
technologies, originally developed by Schmoch (WIPO, 2013c), is used in the present report. 
This hierarchical classification groups IPC classes into 35 technological fields belonging to 
five main technological areas, namely: Electrical engineering, Mechanical engineering, 
Instruments, Chemistry, and Other fields.   
Figure 3.3 shows the distribution of patents across the five technological areas of the 
WIPO classification. The patenting activity of the top 2000 corporate R&D investors 
worldwide appears to clearly focus on technologies related to Electrical engineering, which 
account for almost half of all patent families belonging to these companies. While other 
technology fields appear relatively less important in terms of shares they account within the 
patent portfolios of these companies, they are certainly not when the total numbers of IP5 
patent families are considered. The top 2000 corporate R&D investors considered in the 
present report account for the vast majority of all IP5 patent families in Electrical 
engineering (76%) as well as Mechanical engineering (62%), Instruments (65%) and 
Chemistry (56%), and for the 35% of all IP5 patent families in other technological domains. 
Overall IP5 families owned by the world top corporate R&D investors represent 66% of all 
IP5 families worldwide. 
Figure 3.3 - Distribution of patent families across technological areas, 2010-12 
Share of patent families of world top R&D investors by technological area in overall patent portfolios, 
and share in total patent families by technology area 
 
Source: IPTS-OECD, calculations based on EU R&D Scoreboard data, 2013; and the Worldwide Patent Statistical Database, 
EPO, December 2014. 
Figure 3.4 further details the extent to which top corporate R&D investors file patents in 
the different technological fields. Technological fields are ranked according to their shares 
over the total number of patent families owned by the top corporate R&D investors. The 
distribution of patent families filed by these companies during the period 2010-12 is 
compared with that of 2000-02; the resulting differences are reported in the last column on 
the right.  
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Figure 3.4 - Distribution of patent families across technological fields, 2010-12 - differences with respect to 2000-02 
Share of patent families by technological area (left) and differences with respect to 2000-02 (right) 
 
 
Source: IPTS-OECD, calculations based on EU R&D Scoreboard data, 2013; and the Worldwide Patent Statistical Database, 
EPO, December 2014. 
Top corporate R&D investors appear generally to have shifted their activities away from 
a number of technologies (including Audio-visuals, Optics and Telecommunications) while 
increasing, although to different extents, patenting in fields such as Computer technology, 
Electrical machineries, Semiconductors and Digital communication. 
Inventions related to ICTs appear to have seen the greatest increase in their share over the 
total number of patents owned by the top corporate R&D investors worldwide. 
Computer technology represents the technology in which top corporate R&D investors 
worldwide are the most active, accounting for about 12% of their total patent portfolio. This 
is also one of the two technologies that experienced the highest growth in terms of patent 
filings over time: its share increased by almost 3 percentage points with respect to the 2000-
02 period.  
Electrical machinery and Semiconductors are the second and third most patented 
technologies and have also experienced among the highest patent filing growth, with an 
% in 2010-12 Difference with 2000-02
Computer technology 11.9 2.9
Electrical machinery 10.0 3.0
Semiconductors 7.5 1.0
Audio-visual tech. 6.9 -0.5
Digital communication 6.0 1.0
Optics 5.9 -0.6
Transport 5.1 0.8
Measurement 4.5 0.4
Engines, pumps, turbines 4.1 0.4
Telecommunications 3.4 -1.8
Medical technology 3.2 0.2
Mechanical elements 2.7 -0.1
Textile and paper machines 2.2 -0.7
Handling & logistics 1.9 0.3
Machine tools 1.9 0.2
Surface and coating 1.9 0.2
Basic chemistry 1.8 -0.4
Other special machines 1.7 0.0
Polymers 1.6 -0.6
Control 1.6 0.1
Organic chemistry 1.5 -1.7
Basic communication 1.5 -0.6
Thermal devices 1.3 0.3
Chemical eng. 1.3 -0.3
Materials, metallurgy 1.2 -0.1
Civil eng. 1.1 0.0
Pharmaceuticals 1.1 -1.9
Other consumer goods 1.0 0.0
Environmental tech. 1.0 0.2
Furniture, games 0.9 0.0
IT methods 0.8 -0.5
Biotechnology 0.7 -0.9
Food chemistry 0.3 -0.1
Bio materials 0.3 -0.2
Micro- and nano-tech. 0.2 0.1
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increase in percentage points of 3 and 1, respectively.  
While the number of pharmaceutical top corporate R&D investors in the sample is high – 
they account for about 15% of the top corporate R&D investors and for 20.3%
19
 of total R&D 
expenditures – Medical technologies and Pharmaceuticals account for a low share of patents 
(about 3%, and 1%, respectively in 2010-12). This could be expected given the statistics 
shown on the propensity to patent of companies belonging to the ‘Pharmaceuticals’ industry. 
Moreover, whereas the relative weight of Medical technologies has slightly increased over 
the period considered, the other technologies related to the ‘Pharmaceuticals’ industry (as 
shown also later) have declined in terms of relative weight in the sample: Pharmaceuticals (-
1.9 percentage points), Organic chemistry (-1.7), Biotechnology (-0.9), and Basic chemistry (-
0.4).  
These differences may be driven by a wide array of industry-, firm- and product-specific 
characteristics, including differences in the complexity and modularity of the products that 
these industries produce (e.g. mobile phones versus pharmaceutical compounds).  
3.2.2 The technological concentration of patent portfolios 
A concentration ratio (CR) index is here constructed to shed light on the extent to which 
the top corporate R&D investors concentrate their inventive activities in a subset of 
technology fields. The concentration ratio is an index typically used in the competition 
literature to show the market share of the N largest firms in an industry. In the present case, a 
CR4 index is constructed, synthesising the proportion of patents that companies of a given 
industry I file in the top four technology fields in which they patent, out of the 35 
technological fields identified in WIPO (2013c). 
The CR4 for each industry I is calculated as follows:  
𝐶𝑅4,𝐼  =  ∑ 𝑠𝑛
4
𝑛=1
 
where 𝑠𝑛 denotes the share of the n-th technological field over the total patents and 4 is the 
number of technological fields considered (ranked in a descending order) to compute the 
index.  
Figure 3.5 reports the concentration indices for the industries featuring at least 20 of the 
top 2000 R&D investors worldwide. Except for ‘Computers & electronics’, ICT-related 
industries generally present a level of technological concentration that is much higher than 
that of other industries.   
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 The label Pharmaceutical denotes companies operating in the 'Health Care Equipment & Services' sector, and  
in 'Pharmaceuticals & Biotechnology'.  
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Figure 3.5 –Technological concentration (CR4) by industry, ISIC rev.4, 2010-12 
 
Note: Data relate to industries with at least 20 companies in the top 2000 top corporate R&D investors sample. Figures in 
brackets indicate the number of companies available. 
Source: IPTS-OECD, calculations based on EU R&D Scoreboard data, 2013; and the Worldwide Patent Statistical Database, 
EPO, December 2014. 
The ‘Telecommunications’, ‘Publishing & broadcasting’, and ‘IT services’ industries 
show the highest values in terms of technological concentration of their patent portfolios: 
they file more than 80% of their patents in four technology areas only. ‘Scientific R&D’, 
‘Pharmaceuticals’, ‘Other manufactures’, and ‘Transport equipment’ follow in terms of 
concentration of their inventive activities in selected areas, with values above 60%. Of the 
industries considered, ‘Machinery’ shows particularly low values of CR4 (below 40%), thus 
resulting as the least concentrated industry among those accounting for a high number of top 
R&D investing companies. 
Table 3.1 shows the correlation coefficients between technological concentration, and the 
subsidiary diversification measures discussed in section 2.1. Technological concentration and 
industrial and geographical diversifications appear to be negatively correlated, although to 
different extents, as can be seen from the magnitude of the correlation coefficients. As the 
CR4 index is a concentration measure, its negative correlation with the number of industries 
in which subsidiaries operate indicates that the more technologically diversified companies 
operate in a relatively higher number of industries and are geographically more dispersed, i.e. 
operate in a relatively greater number of countries. In addition, as could be expected, 
operating in a wide array of industries and being geographically diversified are positively 
correlated.   
157
54
47
36
63
22
135
55
68
24
26
35
37
465
66
146
65
150
50
107
83
40
0.0 0.2 0.4 0.6 0.8 1.0
Machinery
Rubber, plastics, minerals
Wholesale, retail, repairs
Law, accountancy & eng.
Finance & insurance
Construction
Chemicals
Electrical equipment
Basic metals
Wood & paper
Textiles & apparel
Electricity, gas & steam
Mining
Computers & electronics
Food products
Transport equipment
Other manufactures
Pharmaceuticals
Scientific R&D
IT services
Publishing & broadcasting
Telecommunications
Number of 
companies
 World Corporate Top R&D Investors: Innovation and IP bundles 
 
36 
Table 3.1 - Correlation of technological concentration and subsidiary diversification, 2010-12 
 
Source: IPTS-OECD, calculations based on EU R&D Scoreboard data, 2013; and the Worldwide Patent Statistical Database, 
EPO, December 2014. 
Mastering a wide array of technological competences is positively linked to operating in a 
large number of industries. The same holds, although not to the same extent, between 
technological and geographical diversification (as the correlation between technological 
specialisation and number of countries in which a company is located is -0.154). Operating 
on a larger geographical scale might not necessarily involve a more diversified knowledge 
base, and activities might to some extent remain at the level of adapting products to the local 
tastes.  
3.2.3 The technological profiles of selected industries 
In what follows, further light is shed on the behaviour of those industries accounting for 
the highest number of top R&D investors. These industries are: ‘Pharmaceuticals', ‘Computer 
& electronics’, ‘Machinery’, and ‘Transport equipment’.  
Figure 3.6 shows the distribution of the patent portfolios over the different technology 
fields. It reveals the relatively higher concentration in a narrow set of technology fields of top 
corporate R&D investors in the ‘Pharmaceuticals’ and ‘Transport equipment’ industries. The 
‘Pharmaceuticals’ industry shows a technological profile based on Pharmaceuticals (mainly 
compounds), Medical technologies and Organic chemistry. With a share of about 10%, 
Biotechnology represents an important technology field on which pharmaceutical companies 
build their competitiveness. Conversely, the ‘Computers & electronics’ industry, which 
accounts for the highest number of top R&D investors in the sample (465 companies), shows 
a more diversified portfolio in terms of the technology focus of its inventive activities. While 
more diversified, though, patenting activities mainly centre on ICT technologies, with 
Electrical machinery, Optics and Measurement representing important technologies for 
companies operating in this industry (share above 5%).  
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CR4 technology 1 1
Number of industries -0.545 1 -0.465 1
Number of countries -0.154 0.704 1 -0.163 0.593 1
Correlation Spearman's rank correlation
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Figure 3.6 - Technological profiles of the 4 most represented industries, ISIC rev.4, 2010-12 
Share of patents owned by selected industries by technology fields  
 
Source: IPTS-OECD, calculations based on EU R&D Scoreboard data, 2013; and the Worldwide Patent Statistical Database, 
EPO, December 2014. 
While displaying clear sector specificities, companies in the ‘Machinery’ and ‘Transport 
equipment’ industries show somewhat similar technological profiles. Both industries have 
important shares of patent portfolios in Engines, Electrical machinery, Mechanical elements, 
Measurement, and Computer technologies. In addition the ‘Machinery’ industry shows 
relevant shares of patents in Machine tools, Material processing, and Audio-visual 
technologies, whereas the ‘Transport equipment’ industry is very focused on Transport 
technologies.     
 
 
 
Technological Field Pharmaceuticals
Computers & 
Electronics
Machinery
Transport 
equipment
Electrical machinery 1 11 8 14
Audio-visual tech. 0 11 5 2
Telecommunications 0 5 2 1
Digital communication 0 10 1 1
Basic communication 0 3 0 0
Computer technology 1 17 7 4
IT methods 0 1 0 0
Semiconductors 1 12 3 1
Optics 1 7 10 1
Measurement 2 5 5 5
Bio materials 2 0 0 0
Control 0 2 2 2
Medical technology 18 3 2 0
Organic chemistry 16 0 0 0
Biotechnology 10 0 0 0
Pharmaceuticals 28 0 0 0
Polymers 3 0 0 0
Food chemistry 1 0 0 0
Basic chemistry 5 1 1 0
Materials, metallurgy 1 1 1 1
Surface and coating 1 2 2 2
Micro- and nano-tech. 0 0 0 0
Chemical eng. 2 1 2 1
Environmental tech. 0 0 2 3
Handling & logistics 1 1 4 1
Machine tools 0 1 6 2
Engines, pumps, turbines 0 1 10 14
Textile and paper machines 0 2 6 0
Other special machines 1 1 3 2
Thermal devices 0 1 2 2
Mechanical elements 0 1 7 9
Transport 0 1 5 28
Furniture, games 0 0 0 0
Other consumer goods 0 1 0 1
Civil eng. 0 0 3 1
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3.3 Technological and economic value of patents 
The technological and economic value of patented inventions is known to vary widely 
across firms and sectors, and over time. Many indicators attempt to capture the different 
meanings that patent value may have for different stakeholders, such as inventors, firms, 
attorneys or policy makers.  
The indicators proposed below are to be considered as proxies of the quality of 
inventions, intended as measures of their technological and economic value. They rely only 
on information contained in published patent documents, and do not integrate any 
information about market transactions or the real use of patented technologies. The patent 
quality indicators used encompass the technological breadth of patents (measured by the 
patent scope), the expected economic value of patents (patent family size), and the extent to 
which the invention can be considered as a radical invention vis-à-vis prior art (see 
Squicciarini et al., 2013, for details about these and other patent indicators). The analysis 
focuses on EPO and USPTO patents that belong to IP5 families. 
As can be seen from Figures 3.7a and 3.7b, ‘Scientific R&D’ services hold EPO patent 
families of relatively high value, featuring strengths in terms of both economic value (family 
size) and technological value (patent scope). Firms in the ‘Chemical’ and ‘Coke & 
petroleum’ industries, as well as in ‘Telecommunications’ and ‘IT services’, and ‘Transport 
services’ seemingly own European inventions of large technological breadth – as measured 
by patent scope - and of a marked technological impact, as measured by the radicalness 
index.  
 
Figure 3.7a – Relative value of EPO patents, average indices by industry, ISIC rev. 4, 2010-12 
 
Note: The data refer to patent applications filed to the EPO that belong to IP5 families. The family size and patent scope indices 
are normalised according to the maximum value observed for patents in the same cohorts (filing date and WIPO technology 
fields). Data relate to industries with more than 150 EPO patents in the given period.  
Source: IPTS-OECD, calculations based on EU R&D Scoreboard data, 2013; and the Worldwide Patent Statistical Database, 
EPO, December 2014. 
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Figure 3.7b – Relative value of USPTO patents, average indices by industry, ISIC rev. 4, 2010-12 
Note: The data refer to patent applications filed to the USPTO that belong to IP5 families. The family size and patent scope 
indices are normalised according to the maximum value observed for patents in the same cohorts (filing date and WIPO 
technology fields). Data relate to industries with more than 150 USPTO patents in the given period.  
Source: IPTS-OECD, calculations based on EU R&D Scoreboard data, 2013; and the Worldwide Patent Statistical Database, 
EPO, December 2014. 
 
The family size index of USPTO patents is, in general, relatively lower than that of EPO 
patents, which may to some extent reflect the attractiveness of the US market vis-à-vis other 
markets and the consequent less marked necessity to extend coverage in other countries, and 
mirror the important presence of US-headquartered top corporate R&D investors.  
In addition, it can be noticed that, in general, USPTO patents feature higher radicalness 
values than EPO ones. This can be due, at least in part, to the fact that information on patent 
citations - on which the radicalness index relies - is available only for USPTO granted 
patents, and not for all patent filings, as is the case for EPO patents. Hence, in the case of 
USPTO the indicator is based on patents known to have succeeded in the patent examination 
process and on a smaller number of observations. 
Comparing the different patent quality indicators proposed, it emerges clearly that, while 
the scope of USPTO patents does not seem to vary much across industries, their radicalness 
does so, with companies in a number of industries including ‘Transport equipment’, 
‘Telecommunications’ and ‘Wood & paper’ that seemingly tend to generate relatively more 
radical innovations.  
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Box 1. The economic and technological value of patents 
 
The quality and value of patented inventions varies from patent to patent, at firm and industry level. A 
wide array of patent quality measures have been proposed in Squicciarini et al. (2013), with the aim of 
capturing the technological and economic value of patents and the possible impact that patents may 
have on subsequent technological developments.  
The proposed indicators rely on a set of information contained in patent documents. Due to 
differences in rules and regulations of patent offices (e.g. different patent classification systems, 
citation procedures, etc.), indicators based on EPO patents shall not be strictly compared with those 
derived from, for example USPTO patents. To account for variations due to the timing and the 
technical specificities of patents, indicators are normalised relying on information from the same 
cohorts, i.e. patents filed in the same technology field in the same year.  
Patent Scope  
The scope of a patent is associated with its technological and economic value. The patent scope index 
is defined as the number of distinct 4-digit subclasses of the IPC to which the invention is allocated. 
The larger the number of IPC classes, the broader the scope index, and the higher the potential 
technological and market value of patents. 
Family Size  
The economic value of patents, i.e. their patent family size, has been found to be associated with the 
number of jurisdictions in which the patent has been sought, and large international patent families 
have found to be particularly valuable. Owing to the Paris Convention (1883), applicants have up to 
12 months from the first filing of a patent application (typically in the country of origin) to file 
applications in other jurisdictions regarding the same invention and claim the priority date of the first 
application. 
The normalised patent family size index shown here refers to the number of patent offices at which a 
given invention has been protected.  
Radicalness index 
The definition of technologically radical inventions proposed here is an adaptation of the one 
proposed by Shane (2001), where the radicalness of a patent is measured as a time-invariant count of 
the number of IPC classes not included in a given patent document but included in the patents cited by 
the same patent document. An invention should therefore be considered radical when a patent cites 
previous patents in different classes from the ones it is in. The higher the ratio, the more diversified 
the array of technologies on which the patent relies. 
 
 
3.4 The international patterns of patent activity 
3.4.1 Patenting strategies across offices 
Looking at the IP offices where top corporate R&D investors worldwide protect their 
inventions may indirectly provide important information about their innovative and market 
strategies. International patent filing strategies may in fact relate to, among others, 
companies’ production and market strategies, to the characteristics of patent regimes and to 
taxation aspects.     
Figure 3.8 shows the distribution of top corporate R&D investors’ patents across the IP5 
offices for the period 2010-12 (on the right), and compares them with similar figures related 
to the 2000-02 and 2005-07 periods. During the 2010-12, USPTO was the most targeted 
patent office by the top 2000 R&D investors worldwide, recording about 33% of the total 
patent family filings. EPO, SIPO and JPO account for similar albeit lower shares of 
applications, i.e. 20% in the case of EPO and 18% in the case of both SIPO and JPO. 
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Inventions patented at KIPO account for the remaining 11% of the total filings of the sample.  
 
Figure 3.8 – Distribution of patent families by IP5 office, 2000-02, 2005-07 and 2010-12 
 
Source: IPTS-OECD, calculations based on EU R&D Scoreboard data, 2013; and the Worldwide Patent Statistical Database, 
EPO, December 2014. 
The above figures reflect to some extent the methodological choice made in this report, 
i.e. to rely on patent applications exhibiting family members filed at least in one of the IP5 
offices, thus excluding single filings, and to use fractional counts. In this way, it is possible to 
avoid double counting, to control for multiple filings of the same invention in different 
locations and to at least partially address the possible bias that may arise as a result of, for 
example, differences in patent procedures across offices.  
Selecting only those patents filed in at least two offices worldwide seemingly has a 
different impact on the overall patent portfolio, depending on the office considered (see also 
section 2.3 in this respect). In particular, comparing the figures presented in this report with 
those of WIPO (2013b), which are based on simple patent counts, important differences arise. 
For instance, in the present report SIPO appears to be the third office in terms of patent 
family applications, whereas in the WIPO report it is the patent office registering the highest 
number of single patent filings (with almost 28% of the total worldwide patent applications). 
Moreover, the shares of USPTO and EPO on the total patent family portfolios are, 
respectively, 10 and 14 percentage points higher than in the WIPO report.  
Considering the patenting activities of the top corporate R&D investors included in the 
present report, significant changes emerge across IP5 offices, over the last 10 years. The 
relative share of patents filed at USPTO declined from about 39% in 2000-02 to 33% in 
2010-12. A similar pattern can be observed in the case of EPO. These apparent decreases are 
partially due to USPTO and EPO experiencing lower patent filings’ growth than that of KIPO 
and SIPO.
20
 SIPO almost doubled its relative importance in terms of IP5 patent applications, 
whereas KIPO’s increase was almost threefold, moving from about 4% of total patent 
applications in 2002-2002 to 11% in 2010-12. 
These relative changes in patent applications across IP5 offices result in a more uniform 
distribution of patent filings over the 2010-12 period (right hand part of figure 3.8) than in 
                                                 
20
 In general terms, the lower number of patent applications observed in the last period might be in due in part to 
the methodology used in the present report. By considering patent applications with family members filed at 
least in one of the IP5 plus another patent office (also at a national level), and given that time is needed to file 
patents at different offices, it might not be possible to fully observe what happens in the latest period, due to 
truncation. 
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2000-02 (see left-hand part) and witness the extent to which the innovation and economic 
landscape has been changing in the last decade. 
The growing importance of the Chinese market and the increasing relevance that IPR are 
having in China
21
 is further reflected in figure 3.9, which shows the distribution of inventions 
filed across patent offices by headquarters location of top R&D investors. Japanese and 
Korean companies file a relatively low share of their inventions at the EPO, corresponding to 
10% and 8% respectively. The tendency to patent at the JPO is even lower for non-Japanese 
companies, the share being always below 5%. On the other hand, Japanese companies do file 
important shares of their patent family portfolios at the UPSTO (31%) and the SIPO (17%). 
Overall, the figure 3.9 shows the extent to which key markets are targeted, and the extent to 
which these figures differ according to the location of the headquarters of top corporate R&D 
investors.  
Figure 3.9 – Family filings at different publication authorities, by companies’ headquarter location, 2010-12 
Number of IP5 patent families by patent office and relative shares 
 
Source: IPTS-OECD, calculations based on EU R&D Scoreboard data, 2013; and the Worldwide Patent Statistical Database, 
EPO, December 2014. 
Interesting insights can also be gained by investigating the extent to which specific 
technologies are patented in some offices rather than in others. 
Figure 3.10 shows the distribution of patents across different technological areas at the 
patent offices considered. As it can be seen, the technological profiles of patent families filed 
at the KIPO, the USPTO and the SIPO are similar: they are largely oriented towards electrical 
engineering applications - with shares that are higher than the sample average - and show 
below average values for the other technology areas.  
 
 
 
 
 
 
 
 
 
                                                 
21
 See, for example, Lei et al (2012) in this respect. 
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Figure 3.10 – Distribution of patents across technological areas by IP5 office, 2010-12 
 
Source: IPTS-OECD, calculations based on EU R&D Scoreboard data, 2013; and the Worldwide Patent Statistical Database, 
EPO, December 2014. 
At the other end of the spectrum are the patents filed at the EPO, where the share of 
patents related to electrical engineering is the lowest, whereas the shares of patents related to 
mechanical engineering and chemistry are above the sample average. Among patents families 
filed at the JPO, the share related to mechanical and electrical engineering is close to the 
sample average and those related to instruments technologies account for a higher than 
average share. The SIPO presents a distribution of patents across technological areas 
mirroring that of the whole sample. 
3.4.2 The relative technological advantages of world's areas 
To shed further light on the technological specialisation of companies headquartered in 
different countries (see section 2.1), a Revealed Technological Advantage (RTA) index has 
been calculated. This provides an indication of the relative specialisation of companies in 
different technological domains (fields). The index is defined as the share of patents in a 
particular technology field of a given area divided by the share of patents in the same 
technology field filed at a global level:  
𝑅𝑇𝐴𝑖𝑡 =  
𝑝𝑠𝑖𝑡/ ∑ 𝑝𝑠𝑖𝑡𝑡
∑ 𝑝𝑠𝑖𝑡𝑖 / ∑ ∑ 𝑝𝑠𝑖𝑡𝑡𝑖
 
where 𝑝𝑠𝑖𝑡 is the number of patents of area i in technology t. The numerator represents the 
share of technology t among all patents of area i, whereas the denominator represents the 
share of technology t among all patents. The index is equal to zero when the headquarters 
country holds no patent in a given technology; is equal to 1 when the area’s share in a 
technology equals the share calculated at the global level (no specialisation); has a value 
between zero and one when a country has a relatively lower share than the one observed at 
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the global level and; has values above 1 when the share is higher (specialisation).  
The comparison of the levels of specialisation in the various technological fields provides 
interesting information about the relative technological strengths of different economic areas 
and headquarters locations. Table 3.2 reports, the RTAs for Europe, the United States, Japan, 
Korea, China and the rest of the world for the period 2010-12. Values of the RTA greater 
than 1 (specialisation) are marked in blue. Europe- and US-headquartered top corporate R&D 
investors show a relative specialisation in a rather high number of technologies, possibly 
reflecting technological advantages in fields requiring a wider range of competences or 
strategies encompassing technological diversification. 
Table 3.2 – RTAs by geographical location of the headquarter, 2010-12 
  
Source: IPTS-OECD, calculations based on EU R&D Scoreboard data, 2013; and the Worldwide Patent Statistical Database, 
EPO, December 2014. 
Moreover, Europe- and US-headquartered top corporate R&D investors are often 
specialised in the very same technologies: Measurement, Bio materials, Medical technology, 
Organic chemistry, Biotechnology, Pharmaceuticals, Food chemistry, Basic chemistry, 
Chemical engineering, Environmental technologies, Machine tools, Mechanical elements, 
Field of Technology Europe United States Japan Korea China
Rest of the 
World
Electrical machinery 1.0 0.7 1.1 1.3 0.5 1.1
Audio-visual tech. 0.4 0.5 1.2 1.6 0.6 2.1
Telecommunications 0.7 0.7 1.0 1.4 3.1 1.3
Digital communication 1.1 1.1 0.6 1.3 8.0 1.2
Basic communication 0.8 1.0 1.0 1.0 1.1 1.7
Computer technology 0.5 1.3 0.8 1.4 1.4 1.8
IT methods 0.8 1.8 0.7 1.0 0.6 1.2
Semiconductors 0.4 0.7 1.1 2.0 0.1 1.5
Optics 0.3 0.4 1.6 1.1 0.2 1.0
Measurement 1.4 1.1 0.9 0.5 0.3 0.8
Bio materials 1.6 1.6 0.7 0.6 0.0 0.1
Control 1.7 1.9 0.4 0.1 0.7 1.3
Medical technology 1.5 1.6 0.9 0.3 0.0 0.2
Organic chemistry 2.0 1.4 0.6 0.3 0.5 0.3
Biotechnology 1.8 1.6 0.6 0.6 0.1 0.2
Pharmaceuticals 2.0 1.8 0.5 0.2 0.1 0.6
Polymers 1.2 0.9 1.1 0.7 0.3 0.5
Food chemistry 2.1 1.8 0.5 0.2 0.0 0.1
Basic chemistry 1.4 1.3 1.0 0.5 0.2 0.3
Materials, metallurgy 1.2 0.7 1.3 0.5 0.3 0.3
Surface and coating 0.8 1.1 1.1 0.7 0.1 1.2
Micro- and nano-tech. 1.2 1.0 0.7 1.3 0.0 1.7
Chemical eng. 1.6 1.4 0.8 0.6 0.3 0.3
Environmental tech. 1.4 1.4 1.0 0.4 0.3 0.1
Handling & logistics 1.2 0.8 1.3 0.2 0.3 0.7
Machine tools 1.4 1.1 1.0 0.2 0.6 0.7
Engines, pumps, turbines 1.5 1.7 0.8 0.4 0.1 0.2
Textile and paper machines 0.5 0.6 1.8 0.2 0.2 0.1
Other special machines 1.4 1.0 1.1 0.3 0.1 0.4
Thermal devices 1.5 0.8 0.9 0.9 0.3 0.6
Mechanical elements 1.6 1.2 0.8 0.5 0.2 0.5
Transport 1.5 1.1 1.0 0.7 0.1 0.2
Furniture, games 1.7 0.8 0.9 0.5 0.7 0.7
Other consumer goods 1.9 0.8 0.7 1.4 0.2 0.4
Civil eng. 1.9 1.8 0.5 0.1 0.5 0.4
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Transport and Civil engineering. Importantly, European and US top corporate R&D investors 
appear to be the only ones specialised in a number of technologies that are fundamental to 
address grand challenges as health, aging and the environment. Their specialisation is 
generally equal or above 1.4 in fields such as Medical technology, Pharmaceuticals, Food 
chemistry, Biotechnology and Environmental technologies. 
With respect to ICT-related technologies, Europe-, United States- and China-based top 
R&D investors appear relatively less specialised in Audio-visual technologies and 
Telecommunications. In contrast to the Unites States, but similarly to Japan, European 
corporates appear also relatively less specialised in Computer technology and IT methods for 
management.  
Compared to Europe and the United States, Japan headquartered companies appear to be 
specialised in a relatively smaller number of technology fields, ranging from ICT to 
machinery, and feature RTA values very close to one (i.e. they are neither over nor under 
specialised) in a wide array of fields, including Measurement and Medical technology. Also, 
Japan is the only location exhibiting a RTA score value above 1 in Textile and paper 
machines technologies, and shares a unique relative specialisation in Handling & logistics 
and Materials, metallurgy and Polymers with Europe. 
The technological specialisation profile of Korean headquartered companies appears very 
much ICT-oriented, with RTA values higher than 1 for Audio-visual technologies, 
Telecommunications, Digital communication, Basic communication, Computer technology, 
IT methods and Semiconductors. Interestingly, Korean top R&D investors are the only 
companies specialised in all ICT-related technology fields, and in complementary areas as 
micro and nano-technologies.   
Top R&D investors headquartered in China appear very much specialised in a subset of 
ICT-related technologies mainly linked to communications. In particular, China-based 
companies show RTA values higher than one in four technologies, namely: 
Telecommunications, Digital communication, Basic communication, and Computer 
technology.  
Top corporate R&D investors located in the rest of the world also appear to be very much 
specialised in ICT-related technologies. 
3.4.3 The international roots of patented inventions  
International knowledge sourcing constitutes a pivotal dimension today’s worldwide 
innovation dynamics. In order to gain or maintain their competitive edge, companies may 
increasingly rely on international knowledge networks, often  through cross-borders 
ownership, mergers and acquisitions, greenfield investments, collaborations and contractual 
research, and intellectual property transactions. At the same time, economies strive to 
strengthen their attractiveness for (large scale) technology and knowledge intensive activities, 
to boost high-quality jobs and competitiveness.  
According to Figure 3.11, about 25% of top corporate R&D investors’ patents have been 
developed by teams of inventors residing in countries that do not correspond to the 
headquarters’ country. The extent to which companies rely on international knowledge varies 
depending on the industry that companies belongs to. Top corporate R&D investors operating 
 World Corporate Top R&D Investors: Innovation and IP bundles 
 
46 
in ‘Mining’, ‘Finance & insurance’ and ‘Pharmaceuticals’ are the most reliant on 
international teams of inventors, with more than 50% of patents being developed by inventors 
located abroad. Conversely, companies in a number of industries, including ‘Basic metals’, 
‘Coke & petroleum’ and ‘Construction’, present relatively lower shares of patents benefiting 
from international groups of inventors.  
 
Figure 3.11 – Patents based on inventions made abroad, by industry, ISIC, rev.4, 2010-12 
Share of patents with at least one inventor located outside the company’s location 
 
Note: Data relate to industries with at least 150 EPO and USPTO patent family members.  
Source: IPTS-OECD, calculations based on EU R&D Scoreboard data, 2013; and the Worldwide Patent Statistical Database, 
EPO, December 2014. 
Figure 3.12 shows that, on average, top corporate R&D investors’ patents have been 
developed in five countries. Also, as all technology-specific distributions appear positively 
skewed and the average number of inventors’ countries is close to the 75th percentile, it can 
be inferred that a small number of companies, relying on inventors located in a large number 
of countries, drives average values. Moreover, it can be clearly seen that half of the 
companies in the top corporate R&D investors’ sample generally rely on pools of inventors 
located in one to four countries.    
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Figure 3.12 – Diversification of inventors’ location by industry, ISIC, rev. 4, 2010-12 
Number of inventors' countries in companies' patent portfolios by industry (EPO and USPTO) 
 
Note: The data are based on all the inventors’ countries listed in each company’s patent portfolios. Data relate to industries with 
at least 10 companies in the top 2000 corporate R&D investors sample. 
Source: IPTS-OECD, calculations based on EU R&D Scoreboard data, 2013; and the Worldwide Patent Statistical Database, 
EPO, December 2014. 
The extent to which companies rely on a geographically diversified knowledge base to 
develop new inventions also appears to vary greatly across industries. Patents from ‘Mining’, 
‘Coke & petroleum’ and ‘Chemicals’ industries have been, on average, developed by highly 
international teams of inventors. Conversely, and possibly against expectations based on a 
concept of science and research that becomes more and more open, patents developed by 
‘Scientific R&D’ companies rely on comparatively smaller and more local teams of 
inventors.  
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4. The trademarks portfolio of top corporate R&D investors 
worldwide 
Key findings 
 The geographical distribution of trademark (TM) applications is largely driven by the 
headquarters’ location 
 TM applications are concentrated in few classes and products fields 
 TM behaviours exhibit market specificities 
 TM applications feature salient industry specificities 
 The adoption of common word mark strategies in international markets remains limited  
 
Trademarks are distinctive signs such as words, pictures, logos, shapes, colours, sounds 
or any combination of these, allowing companies to differentiate their goods and services 
from those of their competitors. Trademarks are meant to reduce information and transaction 
costs for customers, by helping them to identify and choose the products and services that 
best suit their needs. Depending on the IP office where firms apply for trademarks, the 
exclusive right to use these distinctive signs can be acquired on the basis of actual use or 
intent-to-use in commerce.
22
  
Trademark filings have reached unprecedented levels in the last decades, mainly 
reflecting the growing importance for companies to distinguish their products from those of 
their competitors. This surge in trademark filings worldwide might have been driven by a 
number of factors, including the progressive globalisation of economic activities, the 
increasing role of services and service-intensive industries, and the need to move away from 
mere price-based competition.  
In addition, recent evidence suggests that trademarks relate to the launch of new products 
and services (Mendonça et al, 2004; Millot, 2012; and EPO-OHIM, 2013; OECD, 2013). As 
such, indicators based on trademarks may represent useful complements to traditional 
indicators of innovative activities based on patents or R&D investment, to shed light on non-
R&D based innovations and innovation in the services sector.  
The present section shows some statistics related to the trademark applications of top 
corporate R&D investors worldwide using data from four IP offices, namely: the OHIM, the 
USPTO, the JPO and IP AUS. It aims at offering some insights about the geographical and 
industry-specific distribution of trademark activities and the relative importance of distinct 
product fields, based on information contained in the TM applications of top corporate R&D 
investors. Furthermore, it sheds light on the differences that exist in firm-specific trademark 
intensities, as measured by the number of trademarks per Euro of net sales, and provides 
evidence about TM product fields concentration ratios at the industry level. To better 
understand the international strategies of the companies in the sample, trademarks activities 
are compared across IP offices. Finally, an experimental analysis based on common word 
                                                 
22
 In most jurisdictions trademark rights can be maintained subject to the actual use of the trademark. Failure to 
actively use the mark may expose the registration to removal from the register after a certain period of time 
(generally, three to five years). Certain jurisdictions, such as the United States, require actual use even for 
application purposes, although the Trade Related Aspects of Intellectual Property Rights Agreement (TRIPs, 
Article 15) states that it may constitute a condition for registrability, but not a condition for filing an application 
for registration.  
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marks, i.e. marks consisting solely of words and that are registered at different offices, is 
proposed.  
4.1. The origins of trademark applications  
4.1.1. Trademark activities by headquarters’ location 
Figure 4.1 shows the number of trademark applications by headquarters location and IP 
office of filing during the period 2010-12. Figures are ranked according to the amount of 
USPTO applications. In brackets it is shown the overall number of top corporate R&D 
investors headquartered in the country considered. Only countries featuring a minimum of ten 
corporate R&D performers are included in the figure.  
Figure 4.1 – Trademark applications in the four offices, by companies’ headquarter location, 2010-12 
 
 
Note: Trademark counts are based on the application date, the address of the applicant’s headquarters and fractional counts. 
The number in brackets corresponds to the number of companies in the total 2013 sample of top R&D investors. Data relate to 
countries with at least 10 companies in the top 2000 corporate R&D investors sample. Countries are ranked according to 
USPTO figures.  
*Data for JPO are up to May 2012. 
Source: IPTS-OECD, calculations based on EU R&D Scoreboard data, 2013; and OECD Trademark database (internal), 2014. 
 
Overall, the differences in the total number of TM applications reflect the distribution of 
headquarters across countries, with comparatively larger groups of companies that tend to 
show higher volumes of trademarks. The picture that emerges is consistent with the one 
observed when analysing patenting patterns.  
While the vast majority of TM applications at JPO belongs to home-based companies, i.e. 
companies located in Japan (80% of all applications), US-based companies, which account 
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for the majority of companies in the sample, exhibit important trademarking activities both at 
home and abroad. US-based top R&D investors actually account for the highest number of 
TM registrations requests at any of the offices considered, but the JPO. This may mirror the 
higher number of companies in the sample, but also a relatively higher penetration of US-
based top R&D investors in worldwide markets.  
In terms of overall number of trademarks, top corporate R&D performers headquartered 
in Germany, the United Kingdom and France follow their US and Japanese counterparts. As a 
word of caution, it should be noted that, in the case of Europe-based corporate R&D 
investors, the substantially lower numbers observed might be explained to some extent by the 
coexistence of national systems with the OHIM, and the likelihood that trademarks are 
protected at the relevant national offices. 
 
 
While German and Italian companies exhibit similar numbers of TM applications at the 
USPTO and the OHIM, the same in general does not hold for the other European Union-
headquartered R&D investors, or for investors located in OECD countries (e.g. Switzerland 
and Korea). The differences that emerge in terms of numbers of TM applications filed by the 
companies in the sample across the IP offices considered suggest the existence of clear 
preferences in terms of target markets.  
Comparatively low trademarks volumes are also observed in the case of Asia-based top 
R&D investors (excluding Japanese companies). Due to the lack of additional information 
from these Asian countries, it is not possible to assess the extent to which these relatively low 
numbers reflect actual strategies and company behaviours, or simply the impossibility to get a 
more complete and balanced picture. 
The generally higher level of trademark activities at the USPTO and the OHIM may 
reflect the sheer size and market attractiveness that the United States economy and Europe 
represent, and the rate at which new goods and services are launched on those markets.
23
  
Noteworthy is the particularly high penetration of trademarks belonging to Switzerland-
based top R&D investors in Australia, mainly related to pharmaceutical products. This may 
be explained by the fact that the Australian economy is very active in various sub-fields of 
the pharmaceutical industry
24
 such as, bio-medical research, biotechnology, originator
25
 and 
generic medicines.  
4.1.2. Goods and services trademark applications 
Trademark applications may each designate one or several classes of the so-called ‘Nice 
classification’, which details the types of goods and services that trademarks may relate to. 
This classification comprises 45 classes, 34 relating to goods and 11 to services.
26
 The 
specification of goods and services classes limits the scope of the exclusivity right conferred 
                                                 
23
 The relatively lower level of applications at JPO is partly due to fact that our data are only up to May 2012. 
24
 See 
http://www.industry.gov.au/industry/IndustrySectors/PharmaceuticalsandHealthTechnologies/Pharmaceuticals/P
ages/PharmaceuticalsIndustryDataCard.aspx  
25
 Non-generic medicines companies, see 
http://ec.europa.eu/competition/sectors/pharmaceuticals/inquiry/2_Originator_Generic_competition.pdf  
26
 See the 2015 version of the tenth edition of the “Nice Classification” or the International Classification of 
Goods and Services for the Purposes of the Registration of Marks (10th ed. 2015).  
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to the owner and, at the same time, prevents the exploitation of similar or identical signs by 
others in the designated classes. 
All the four IP offices considered in the present report allow for a multi-class filing 
system, i.e. that applicants may use a single TM application to protect good and services 
belonging to several classes. Thus, the overall number of TM applications recorded is lower 
than it would have been in a single-class filing system such as the Chinese system.
27
 In multi-
class trademark systems, fees generally increase with the number of classes designated in an 
application. 
Most trademark applications of top corporate R&D investors refer only to goods or to 
goods and services classes jointly, although the distribution varies across IP offices. As 
shown in Figure 4.2, the share of joint goods and services TMs applications of top corporate 
R&D investors is, in general, higher at the OHIM than at the other offices considered. This 
may to some extent be explained by the fee system in place at the OHIM, where applicants 
can designate up to three classes upon payment of the basic fee, and extra fees apply only 
from the fourth class of goods or services designated in an application.  
Top corporate R&D investors with headquarters located in Austria, Norway and Spain 
exhibit peculiar patterns in this respect, as more than half of their TM applications jointly 
relate to goods and services classes at the OHIM. This share goes above 80% in the case of 
Austria-based R&D investors. In addition, Norwegian top corporate R&D investors do not 
own any trademark solely related to services, except at the USPTO. 
In most cases, less than one fifth of the TM applications of top R&D investors relate to 
services classes only. Exceptions include TM applications of Australia-based R&D investors 
at IP AUS and of Canada and Spain-based companies, especially at the USPTO.  
Top R&D investors do not show higher shares of service-marks applications in their 
domestic markets than in foreign markets. This contrasts with the trends observed over all 
applicants at the USPTO, the OHIM and the JPO during the same period (see OECD STI 
2013). The share of service-only marks is in general higher at the USPTO than at the OHIM 
or the JPO.   
 
                                                 
27
 In a single-class filing system, applicants have to file distinct applications for each and every class they want 
their trademarks to designate. This is the case of China, for instance, where single class TM are filed. For more 
details about countries that allow single or multiple class filings, visit the web of the “International Trademark 
Association” (INTA, http://www.inta.org/Pages/Home.aspx), in particular  
http://www.inta.org/TrademarkBasics/FactSheets/Documents/Single%20Class%20vs%20MultiClass%20TM%2
0Applications%20Chart.pdf. 
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Figure 4.2 –Share of goods and services trademark applications at the four offices, by companies’ headquarter location 2010-12 
 
Note: Trademark counts are based on the application date and the address of the applicant’s headquarters (using fractional counts). Data relate to countries with at least 10 
companies in the top 2000 corporate R&D investors sample. 
Source: IPTS-OECD, calculations based on EU R&D Scoreboard data, 2013; and OECD Trademark database (internal), 2014. 
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4.1.3 Main trademarks application fields by headquarters’ location 
To try to link trademarks fields to industries, the OECD (2013) has proposed product 
fields aggregates that group goods and services TM classes in a homogenous fashion with 
respect to the industry they might relate to.
28
 This correspondence thus mainly relies on a 
qualitative assessment about the goods or services themselves, and the industries that are 
typically known to produce them. 
Figure 4.3 shows the top three trademark application fields by office and location of the 
headquarters. The evidence suggests that, in general, top corporate R&D investors’ TM 
applications relate to the same product fields in the four offices when two of the top three 
fields (in terms of number of applications) are considered. Differences conversely exist with 
respect to the top third field designated and with respect to the shares that the top three fields 
account for.  
Only top corporate R&D investors headquartered in the United Kingdom, Sweden and the 
United States appear to consistently file the majority of their TM applications in the same 
three top classes, although differences exist in the proportion that these classes represent.  
In general, the TM applications of top R&D investors are concentrated in two fields, 
Health, pharma and cosmetics and ICT and audiovisuals. This pattern is more pronounced 
for companies headquartered in China and South Korea, exhibiting more than 60% of their 
applications in the ICT and audiovisual field at the USPTO, the OHIM and the JPO. A 
similar level of specialisation is observable in Health, pharma and cosmetics in the case of 
top corporate R&D investors from Denmark and Switzerland, as well as for India-based 
companies (but only at the USPTO and the OHIM).  
Noteworthy is the similarity of Japanese and United States top R&D investors’ profiles at 
the USPTO and the OHIM, which suggests that they pursue similar trademarking strategies in 
the two markets considered. In addition to being active in ICT and audiovisual and the 
Health, pharma and cosmetics, Japan and the United States’ companies show a non-
negligible activity in the Leisure and education field.  
Significant shares related to the Leisure and education field are also observable in the 
case of Finland-based HQs. Italian top R&D investors show relatively higher shares of 
transport-related trademarks at the USPTO, the JPO and the IP AUS. Transport related-
trademarks also feature among the top three TM fields of Germany- and India-based 
companies at the OHIM, the USPTO and the IP AUS.  
                                                 
28
 The groups are as follows: Advertising and business services: classes 35, 36 and 45; Agricultural products: 
classes 29, 30, 31, 32, 33 and 34; Chemicals: classes 1, 2 and 4; Clothes, textiles and accessories: classes 14, 18, 
22, 23, 24, 25, 26; Construction: classes 6, 17, 19, 27 and 37; Furniture and household goods: 11, 20 and 21; 
Health, pharmaceuticals and cosmetics: classes 3, 5, 10 and 44; ICT and audiovisual: classes 9 and 38; Leisure 
and education: classes 13, 15, 16, 28 and 41; Research and Development (R&D): class 42; Tools and machines: 
classes 7 and 8; Transport: classes 12 and 39, Hotels, restaurants and other services: classes 40 and 43. 
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Figure 4.3 – Top three trademark application fields, by office and companies’ headquarter location, 2010-12 
 
Note: Trademark counts are based on the application date, the address of the applicant’s headquarters and the designated Nice classes (using fractional counts). Data relate to countries 
with at least 20 companies in the top 2000 corporate R&D investors sample. 
Source: IPTS-OECD, calculations based on EU R&D Scoreboard data, 2013; and OECD Trademark database (internal), 2014. 
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4.2. Corporate trademark applications by industry and international class 
4.2.1. Trademark applications by industry 
In what follows, the indicators proposed shed light on the industry-specific trademark 
activities of top corporate R&D investors.  
In contrast to patents, trademarks can be used in a number of instances and for a wide 
array of purposes, for example, to signal the creation of a new business or when launching a 
new product or service. Hence, the likelihood that firms belonging to all industries use 
trademarks, including services industries, is very high, although the propensity to rely on 
trademarks and the trademarking strategies of firms may differ from one industry to another.  
Figure 4.4 shows the industry-specific average number of trademark applications filed by 
the top corporate R&D investors over the period 2010-12. Statistics are presented by industry 
of the headquarters. Figure 4.5 further displays the by-industry TM intensity ratios, i.e. the 
number of TMs filed over sales. For comparison purposes, top corporate R&D investors are 
assigned to only one industry (ISIC, revision 4), corresponding to their principal field of 
economic activity. 
Figure 4.4 – Average number of TM applications per company, by main industry affiliation, ISIC rev. 4, 2010-12 
 
Note:  Trademark counts are based on the application date, the main industry of the applicant’s corporate group and fractional 
counts. The industry classification used refers to an aggregation of the NACE, rev. 2 list into 38 industries. Industries are 
ranked according to USPTO figures. The overall number of firms assigned to each industry is displayed on the vertical axis, in 
parentheses. Data relate to industries with at least 10 companies in the top 2000 corporate R&D investors sample.  
*Data for JPO are up to May 2012. 
Source: IPTS-OECD, calculations based on EU R&D Scoreboard data, 2013; and OECD Trademark database (internal), 2014 
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While suggesting the existence of broad industry-specific patterns, the numbers shown in 
Figure 4.4 hide the substantial heterogeneity that can be observed by looking at the within- 
industry distribution of TM applications (shown in Appendix 1). No clear pattern emerges 
with respect to the number of top corporate R&D investors in an industry and the extent to 
which they rely on trademarks. Relatively smaller (larger) groups of top R&D investors 
appear all along the distribution of the average number of TM applications per company. 
High ratios are found in small-size groups such as ‘Textiles & apparel’, as well as in 
medium-sized groups such as ‘Food products’, ‘Electrical equipment’ and in industries 
featuring relatively larger groups of top R&D investors, such as ‘Pharmaceuticals’ and 
‘Chemicals’.  
As could be expected, in most cases the average number of trademarks per company is 
higher at the USPTO and the JPO than at the OHIM. This may to some extent result from the 
coexistence in Europe of national trademark systems and the CTM system.  
Also, comparing the average number of trademark applications at the USPTO and the 
JPO shows the extent to which they differ by industries and points to the possible existence of 
‘home’-specific behaviours, especially at JPO. This is further confirmed by the comparatively 
high value of JPO-related trademarks in industries such as ‘Food products’, ‘Chemicals’, 
‘Textiles & apparel’ and ‘Construction’, which are dominated by Japan-headquartered top 
corporate R&D investors (representing more than 30% of the total R&D investors in each 
industry). 
Figure 4.5 shows statistics related to trademark intensity, intended as the average ratio 
of corporate TM applications divided by corporate net sales in each industry.
29
 The index 
corresponds to the number of trademarks per billion Euros of net sales.  
This index appears to vary widely across industries, thus suggesting that while all the 
companies in the current sample are ‘heavy’ R&D investors, they pursue different trademark 
strategies. Some top corporate R&D investors may rely on one or a few trademarks for a 
wide range of products (e.g. in the ‘Transport services’), or conversely file several trademarks 
for each product or service launched on the market (e.g. in the ‘Pharmaceuticals’ industry).  
Again, as in the case of the average number of trademarks by company, no clear 
relationship emerges between the number of top corporate R&D investors in an industry and 
the ratio of trademarks over sales. Also, no clear pattern emerges with respect to whether it is 
services industries or manufacturing ones that show the highest TM intensity. Top performers 
include ‘Scientific R&D’, ‘Finance & insurance’, ‘IT services’ and ‘Publishing & 
broadcasting’, as well as ‘Pharmaceuticals’ and ‘Other manufactures’ and ‘Coke & 
petroleum’. 
 
 
  
                                                 
29
 At the individual corporate level, trademarks and net sales are computed as averages of the TM applications 
for the available years on the period 2010-12. 
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Figure 4.5 – Trademark intensity by industry, ISIC rev. 4, 2010-12 
Average number of trademark applications over net sales in billion Euros 
 
Note: Trademark counts are based on the application date, the main industry of the applicant’s corporate group and fractional 
counts. The industry classification used refers to an aggregation of the NACE, rev. 2 list into 38 industries. Industries are 
ranked according to USPTO figures. Overall number of firms with sales information available in 2010, 2011 or 2012 in each 
industry displayed on the vertical axis, in parentheses. Data relate to industries with at least 10 companies with sales 
information in the top 2000 corporate R&D investors sample. 
 *Data for JPO are up to May 2012 
Source: IPTS-OECD, calculations based on EU R&D Scoreboard data, 2013; and OECD Trademark database (internal), 2014 
However, by comparing patenting propensities (shown in Figure 3.1) with trademark 
intensities, interesting industry-specific behaviours emerge. ‘Publishing & broadcasting’, 
‘Scientific R&D’ and ‘Pharmaceuticals’ appear as low-patent-propensity but high-TM-
intensity industries. This means that while they file relatively small numbers of patents 
related to the R&D investment they make, they apply for a relatively high number of 
trademarks in relation to their sales volumes. That is, one patent is likely associated to more 
than one trademark. At the other end of the spectrum can be conversely found industries as 
‘Basic metals’ and ‘Rubber, plastics & minerals’, featuring high patent propensities but low 
trademark intensities. This might mirror the very nature of these industries, which generally 
rely on sophisticated technologies to produce intermediate goods, and hence do not reach out 
to final consumers to the extent that others, e.g. ‘Pharmaceuticals’, do. Finally, ‘Construction’ 
and ‘Electricity, gas & steam’ companies generally exhibit low patent propensities as well as 
low trademark intensities. Industry structure and competition settings might in this case 
explain such behaviours.  
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4.2.2 Trademark applications by good and service classes 
The distribution of applications by international class shown in Figure 4.6 allows 
assessing the extent to which top corporate R&D investors use trademarks to differentiate 
their goods or services on the market, to try to steer customers’ choices.30  
Two goods-related classes, namely Instruments and computers (class 9) and Pharma 
products (class 5) are persistently designated in at least 10% of top corporate R&D investors’ 
TM applications in all IP offices considered (up to 20% of applications at the USPTO for the 
former class). Although with lower shares, Cleaning products (class 3) and Medical 
instruments (class 10) also appear as important products lines of top corporate R&D 
investors.  
Marked differences across the offices considered also emerge, with the USPTO showing 
a comparatively higher share of designations in Games (class 28). In the case of JPO, classes 
as Cleaning products (class 3) and Condiments and cereals (class 30) show relatively higher 
values than in other offices, a fact which may, to some extent, reflect the important share of 
Japan-headquartered top R&D investors operating in the ‘Chemicals’ and ‘Food products’ 
industries, as shown before. Similarly, the relatively higher shares of Pharma products at IP 
AUS may be explained by the importance of the pharmaceutical industry in that continent.  
A closer look at services classes suggests that R&D and software (class 42) is the most 
designated services class in all offices considered, and features among the top five classes at 
both the USPTO and the OHIM. Other important services classes in all offices include 
Business and advertising (class 35) and Education and sport (class 41).  
In general, services classes account for relatively lower shares of top corporate R&D 
investors’ applications both at the JPO and at the IP AUS. These differences are likely to be 
driven by several factors, including the specific fee system in place and the structure of the 
economies considered. 
  
                                                 
30
 A fractional counting method is used to compute the share of goods and services classes designated in 
trademark applications. This means that if, for example, an application designates four classes, each class will 
be counted as 0.25. 
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Figure 4.6 – Distribution of trademark applications by international class, 2010-12 
 
Note: Trademark counts by international classes are based on the application date and fractional counts. Classes are ranked 
according to USPTO figures. Classes’ titles correspond to short labels based on the International Classification of Goods and 
Services for the Purposes of the Registration of Marks (Nice classification). For an exact description of the classes, see 
www.wipo.int/classifications/nivilo/nice/index.htm  
Source: IPTS-OECD, calculations based on EU R&D Scoreboard data, 2013; and OECD Trademark database (internal), 2014. 
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4.2.3 Concentration of trademark classes by industry of origin 
Figure 4.7 shows statistics related to the concentration ratio of TM classes by industry of 
origin. This ratio corresponds to the average, at the industry-level, of the firm-specific shares 
of the three most frequently designated Nice classes contained in trademark applications. To 
ensure comparability across offices, the concentration ratio is based on the share of the top 
three classes, as this is the number of classes that can be designated at OHIM against 
payment of the basic fee (whereas ‘pay-per-class’ systems exist at the other offices).  
In most industries, the concentration ratio appears to be lower at the USPTO than at the 
OHIM or the JPO, thus signalling strategies that rely more on customisation and 
diversification in the United States than in the other markets considered. The distribution of 
trademark applications across companies at the different offices (shown in Appendix 1) 
provides additional insights about the concentration of trademarking activities of top 
corporate R&D investors. The distribution of trademark applications at JPO and OHIM 
appears to be more skewed than at the USPTO, a fact which contributes to explain the overall 
differences in concentration ratios observed across the offices. 
Some services industries, e.g. ‘Law, accountancy & engineering’, ‘Wholesale, retail, 
repair’ and ‘Telecommunications’, appear to be relatively concentrated in terms of product 
classes they rely upon, and compared to manufacturing industries. This may be due to the 
design of the Nice classification, where service classes (11 classes) tend to be more 
aggregated than good classes (34 classes).  
A number of interesting stylised facts emerge by comparing TM product class 
concentration with the patent-based technological concentration patterns shown in Figure 3.5.  
Some industries that are technologically specialised, in terms of patent fields they mostly rely 
upon, appear relatively diversified in terms of products trademarked. This is the case, for 
instance of ‘Scientific R&D’ and ‘IT services’. Plausibly, the technologies developed by 
these industries may have a wide range of commercial applications. Conversely, companies 
in ‘Wholesale, retail, repairs’ own patents belonging to a relatively broad range of 
technologies, but rely on few TM product classes. To some extent this might be due to the 
somewhat heterogeneous nature of Nice classes and the consequent need or lack thereof to 
rely on multiple classes, or the specialisation of companies in different trade domains.  
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Figure 4.7 – Product class concentration ratio (CR3) of trademark applications by firms, industry average, 2010-12 
 
Note: Trademark counts are based on the application date and the main industry of the applicant’s corporate group. The 
industry classification used refers to an aggregation of the NACE, rev. 2 list into 38 industries. Data relate to industries with at 
least 20 companies in the top 2000 corporate R&D investors sample. The CR3 ratio is calculated as an industry average of the 
share of the top three Nice classes in each firm’s trademark applications at the various offices considered. Industries are 
ranked according to USPTO figures.  
Source: IPTS-OECD, calculations based on EU R&D Scoreboard data, 2013; and OECD Trademark database (internal), 2014. 
 
4.2.4 Knowledge-assets related trademarks 
Relying on Nice classes and keyword searches in the descriptions of goods and services 
contained in TM applications,
31
 it is possible to identify trademarks related to various 
knowledge-based-assets (OECD STI, 2013). Three main categories can be identified in this 
respect, namely: R&D-related, ICT-related and IP-transactions-related TMs. Figures 4.8, 4.9 
and 4.10 break down the TM applications of top corporate R&D investors in these three 
categories, by headquarters’ location.  
The number of R&D-related trademarks per company and headquarters’ country reported 
in Figure 4.8 reflects the activities of top corporate R&D investors in the Nice class 42. Such 
activities mainly aim at protecting scientific and technological services and related research 
and design services, industrial analysis and research services, and the design and 
development of computer hardware and software. These R&D-related TM applications 
appear to mainly stem from top corporate R&D investors headquartered in a few countries, 
known to have very developed and competitive markets for research. These include large 
countries such as France, Germany, the United Kingdom, the United States and Japan 
                                                 
31
 In addition to the Nice classes, TM applications must contain the list of goods and/or services for which 
trademark protection is sought. The items may be chosen by the applicant or selected from a list of goods and 
services previously validated by the office (offices generally recommend using the latter option, as submitting 
non-validated terms may lead to delays in registration).  
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featuring high R&D spending and smaller countries, including Denmark, Finland, Sweden, 
Netherlands with high spending for R&D relative to their size.  
A sort of ‘home’ bias clearly emerges, with Europe-based top R&D investors (with the 
exception of Switzerland-headquartered companies) showing a higher ratio of per company 
applications at the OHIM; US-based companies at the USPTO; and Japan-based companies at 
the JPO. This may reflect the importance of the home market when it comes to the protection 
of R&D-related assets and the relatively lower tradability of services as compared to 
manufactured goods. 
Figure 4.8 – Number of R&D-related TM applications per company by headquarter location, 2010-12 
 
Note: Trademark counts are based on the application date, the address of the applicant’s headquarters, and fractional counts. 
R&D-related trademarks refer to trademark applications designating class 42 of the Nice Classification. The overall number of 
firms assigned to each country displayed on the vertical axis, in parenthesis. Data relate to countries with at least 20 companies 
in the top 2000 corporate R&D sample. Countries are ranked according to USPTO figures.  
*Data for JPO are up to May 2012. 
Source: IPTS-OECD, calculations based on EU R&D Scoreboard data, 2013; and OECD Trademark database (internal), 2014. 
 
ICT-related trademark refer to TM applications in Instruments and computers (class 9), 
Games (class 28), Business and advertising (class 35), Telecommunications (class 38), 
Education and sport (class 41) and/or R&D and software (class 42) containing ICT-related 
keywords in the goods and services description.
32
 Figure 4.9 shows that ICT-related TM 
applications of top R&D investors also belongs to companies headquartered in few countries 
featuring high absolute or relative levels of domestic R&D activities. The higher number of 
per company ICT-related TM applications belonging to top corporate R&D investors located 
in these countries may also signal the existence of specific corporate diversification and 
brand strategies, the size and sophistication of the local markets as well as the industrial and 
specialisation patterns of these economies.     
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Figure 4.9 – Number of ICT-related TM applications per company by headquarter location, 2010-12 
 
Note: Trademark counts are based on the application date, the address of the applicant’s headquarters, and fractional counts. 
ICT-related trademarks refer to trademark applications designating classes 9, 28, 35, 38, 41 and/or 42 of the Nice Classification 
and containing ICT-related keywords in the goods and services description (complete list of keywords available on 
demand).The overall number of firms assigned to each country is displayed on the vertical axis, in parenthesis. Data relate to 
countries with at least 20 companies in the top 2000 corporate R&D investors sample. Countries are ranked according to 
USPTO figures. 
Source: IPTS-OECD, calculations based on EU R&D Scoreboard data, 2013; and OECD Trademark database (internal), 2014. 
 
IP transaction-related TMs relate to the protection, management and commercialisation of 
IP rights, IP consultations and legal mediation in the field of IP. These trademarks are 
identified through a keyword search among trademarks registered in Legal and personal 
services (class 45). The number of IP transaction-related TM applications per company 
appears very low, and signals that IP-related activities are only seldom branded and marketed 
in a somewhat independent fashion. The differences observed across the offices considered 
may to some extent reflect the relative importance or level of development of the markets for 
IP services in the countries considered.   
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Figure 4.10 – Number of IP transactions-related TM applications per company by headquarter location, 2010-12 
 
Note: Trademark counts are based on the application date, the address of the applicant’s headquarters, and fractional counts. 
IP transactions-related trademarks refer to trademark applications designating class 45 of the Nice Classification and 
containing keywords related to IP transactions in the goods and services description (complete list of keywords available on 
demand). The overall number of firms assigned to each country is displayed on the vertical axis, in parenthesis. Data relate to 
countries with at least 20 companies in the top 2000 corporate R&D investors sample. Countries are ranked according to 
USPTO figures. 
Source: IPTS-OECD, calculations based on EU R&D Scoreboard data, 2013; and OECD Trademark database (internal), 2014. 
 
4.3. International trademark activities of top corporate R&D investors  
4.3.1. A geographic perspective  
Figure 4.11 provides a broad overview of the trademark activities of top corporate R&D 
investors by showing the distribution of applications across Nice classes, at three key IP 
offices (the same table including data for IP AUS is available in Appendix 2). In line with 
what observed previously, the TM applications of top corporate R&D investors appear to be 
concentrated mainly in Instruments and computers (class 9) and/or Pharma products (class 
5). This generally holds true irrespective of the location of the headquarters and the office of 
filing, again with the exception of TM applications filed by Japan-headquartered applicants at 
the JPO.  
In terms of service trademarks (highlighted in bold in Figure 4.11), data confirm classes 
R&D and software (class 42), Business and advertising (class 35) and Education and sport 
(class 41) as the most frequently used services classes. 
For EU-based and US-based companies, trademarking activities in the country of the 
headquarters are generally similar to the ones shown in foreign markets, in terms of 
distribution of applications across TM classes. The distributions of Japanese top R&D 
investors’ classes at the USPTO and the OHIM also feature important similarities, and appear 
concentrated in few goods classes, including Vehicles (class 12). 
The higher average number of trademarks and TM intensity observed for applications at 
the JPO in Cleaning products (class 3) and Condiments and cereals (class 30) may to some 
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extent stem from the relatively higher shares of these classes in Japan-based R&D investors’ 
applications. However, the fact that also European firms exhibit a relatively higher share of 
applications in class 3 at JPO signals the possible existence of market-specific behaviours in 
the industry.   
TM applications of Chinese and Korean top R&D investors mainly belong to the 
Instruments and computers class, in all offices considered. Other classes with lower although 
non-negligible shares of TM applications from companies headquartered in these two 
economies include Machinery (class 7) for China-based HQ and Lightening and heating 
(class 11) for top R&D investors headquartered in Korea. 
Finally, and coherently with what observed in section 4.1.2, top R&D investors do not 
generally show higher shares of service-marks applications in their domestic markets than in 
foreign markets. This contrasts with the general trends observed when looking at all USPTO, 
OHIM and JPO applications over the same period (see OECD STI 2013). 
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Figure 4.11 – Distribution of trademark applications by Nice class, by companies’ headquarter location and IP office, 2010-12 
 
 
Note: Trademark counts by international classes are based on the application date and the location of the applicant’s headquarters, using fractional counts. Blue bars and percentages correspond to 
the distribution of Nice classes in the trademark applications of the region and office considered. Classes are ranked according to US figures at USPTO. Data relate to classes representing at least 2% 
of applications of one region at one office, and only percentages higher than 1% are displayed. Grey cells correspond to classes with no applications from the region/office considered. 
Source: IPTS-OECD, calculations based on EU R&D Scoreboard data, 2013; and OECD Trademark database (internal), 2014.  
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4.3.2. Word marks of top corporate R&D investors  
In the case of patents, priority numbers, i.e. cross-reference numbers cited in patent 
documents claiming priority rights,
33
 help tracking patent applications related to the same 
inventions that are filed at several offices. Although trademarks are also given this possibility 
according to the Paris Convention, and priority rights can be claimed within six months from 
the date of the original trademark application, priorities are only seldom used by applicants.  
Only 12% of trademark applications at OHIM between 2008 and 2012 have a priority 
number, and only 2% of USPTO trademarks (13% of non-resident applications) do so. 
Hence, relying on trademark priority data would provide a partial view of the extent to which 
firms use the same brands in different markets.
34
    
To try to shed light on the international trademarking strategies of top R&D investors 
worldwide, an experimental methodology is proposed here. This exploits information about 
the use of the very same word(s) when registering trademarks at different offices, to check 
whether companies use identical or differentiated word marks across markets. Statistics 
suggest that, of the set of distinctive signs that firms may use, word marks constitute the most 
common type of TM applications. 
While this method allows identifying goods and services that are branded in exactly the 
same way in different countries, it nevertheless leads to spotting only those products that 
have identical word marks. This entails overlooking some types of trademarks (e.g. figurative 
or 3-dimensions ones), or trademarks using words having exactly the same meaning in 
different languages (e.g. “Mr Clean” in English-speaking countries, “Mastro Lindo” in Italian 
and “Monsieur Propre” in French). 
Figure 4.12 shows the share of top corporate R&D investors that have applied for 
identical word marks at the OHIM and/or the USPTO and/or the IP AUS between 2008 and 
2012. The values are shown according to the percentage ranges of common word mark 
applications over the total word marks applications of the companies. 
Overall, 61% of top R&D investors have applied for at least one identical word mark at 
the OHIM and the USPTO. This proportion goes down to 51% for a common word mark at 
the USPTO and the IP AUS. Such commonality is lowest between the OHIM and IP AUS, as 
about 39% of these companies have employed an identical word mark in their applications at 
these two offices. Furthemore, less than 2% of top corporate investors have filed all their 
word marks in an identical fashion in any two of the three offices. This suggests that the 
majority of firms tend to use a small set of core common trademarks across all the markets 
considered, and differentiate the majority of their trademark portfolio depending on the target 
market considered. 
 
                                                 
33
 Under the system of priority rights, established by the Paris Convention, applicants have up to 12 months 
from first filing their patent application in which to make further subsequent applications in each signatory 
country and claim the original priority date. The priority number is in particular used to build patent families. 
34
 The very limited use of priorities in trademarks may be partly due to the fact that, in contrast to technologies, 
trademarks are specific to the linguistic and cultural context in which they are supposed to be used. Companies 
thus tend to often adapt their trademarks to different markets. Examples are the French brand ‘Auchan’, which is 
traded as ‘Al Campo’ in Spain; the French brand ‘Danone’ traded as ‘Danonn’ in the United States,  and the 
Coca-Cola Company brand mostly referred as ‘Coke’ in the US, versus ‘Coca-Cola’ in Europe. 
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Figure 4.12 – Share of companies with common word marks across OHIM, USPTO and IP AUS  
by percentage range of common word marks, 2008-12 
 
Note: How to read this figure: 9.7% of top R&D investors have between 20% and 30% of their word marks at OHIM and 
USPTO which are identical in the two offices. 1.4% have filed between 20% and 30% of their word marks at the OHIM, USPTO 
and IP AUS identically in the three offices.  
Source: IPTS-OECD, calculations based on EU R&D Scoreboard data, 2013; and OECD Trademark database (internal), 2014. 
 
Figure 4.13 shows the shares of common word marks across the USPTO, OHIM and IP AUS, 
by headquarters location of the applicant.  
 
Figure 4.13 – Percentage of common word marks between OHIM, USPTO and IP AUS,  
by companies’ headquarter location, 2008-12 
 
Note: How to read this figure: 74% of word marks filed at OHIM and USPTO by New Zealand-based corporate applicants are 
identical across the two offices. 56% of their word marks filed at OHIM, USPTO and IP AUS are identical across the three 
offices. Data relate to countries with at least 100 word mark applications at three offices taken together. Countries are ranked 
according to the share of common word marks in the three offices. 
Source: IPTS-OECD, calculations based on EU R&D Scoreboard data, 2013; and OECD Trademark database (internal), 2014. 
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As can be seen from the table at the bottom of the figure, the percentage of word marks of 
top corporate R&D investors’ trademark applications is always higher than 75% for the 
countries and offices considered.
35
 Except for New Zealand-based top R&D investors, which 
have 56% of identical word marks protected in the three offices considered, companies 
located in other countries feature only a minority of identical word marks across the offices 
considered.   
For most countries, shares are highest in the case of the pair OHIM-USPTO, especially 
for top R&D investors headquartered in China, Luxembourg and India. This suggests that 
companies tend to adopt similar trademarking strategies in the European and the US markets, 
more frequently so than they do on the Australian market. Another common pattern that 
emerges is one whereby English-speaking countries (plus Korea and Israel) feature higher 
shares of common word marks between USPTO and IP AUS than they do at OHIM - IP 
AUS.  
This exploratory comparison of common word mark shares across the different offices 
considered reveals the extent to which TM strategies differ across markets. The figures 
shown might mirror the fact that the same products are branded in different ways in different 
markets or that companies propose (completely or partially) different products in different 
markets, and brand them in a different way. The differences observed might be explained by 
factors such as corporate strategies; local customers’ interests, language, culture and 
sophistication; and, more generally, the extent to which demand patterns – and hence supply 
strategies - differ across markets.  
 
  
                                                 
35
 With the sole exception of the word marks of Bermuda-based top R&D investors which represent 50% of 
their TM applications at the IP AUS. 
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5. The IP bundle: the combined use of patents and trademarks 
Key findings 
 Top corporate R&D investors use patents and trademarks as complementary protection means 
 The joint commonality of patents and word marks is industry specific 
 Few product fields relate to a wide range of patented technologies  
 
The statistics and analysis proposed in previous sections of this report rely alternatively 
on patent or trademark data, with the aim to uncover a wide array of stylised facts related to 
the inventive output and the market and branding strategies of top corporate R&D investors. 
To gain a more comprehensive view of such dynamics, the present section combines patent 
and trademark data. This allows gaining further insights about the extent to which companies 
combine IP tools to better appropriate the results of their inventive activities and to 
successfully bring them onto the market.  
The analysis presented in this section is based on data related to patents and trademarks 
registered at USPTO, EPO and OHIM, and JPO, which are comprised among the IP5 offices 
considered so far. Consistently, patent figures correspond to IP5 patent family members 
found in any of the three offices - a subset of Definition 2 described in Section 2 -, whereas 
trademark data refer to individual applications filed at the different offices.  
USPTO and JPO trademark and patent data can be considered substantially 
homogeneous, as they are registered by the same institution and protected in the very same 
jurisdiction. In Europe, by contrast, trademarks and patents are not administered by the same 
office, and the scope of protection is heterogeneous. EPO patents are bundles of national ones 
and need being validated in each and every country where protection is sought, among the 
countries designated in the patent application. Only seldom EPO patents are validated in all 
the offices that can be designated, based on their being signatories to the European Patent 
Convention (EPC).
36
 Conversely the CTM system grants trademark owners exclusive rights 
in the 28 Member States of the European Union. Additionally, trademarks and patents in 
Europe can also be protected at the country level via the national IP offices routes, which are 
not taken into account in the present report.  
These differences should be kept in mind when reading the figures presented throughout 
this section, as the heterogeneity of the IP assets considered may partially hinder the 
comparability of the statistics shown. 
5.1. The IP portfolio of top corporate R&D investors 
Patents and trademarks may constitute important tools for firms to compete in global 
markets and to differentiate themselves from their competitors. Hence, the joint analysis of 
patents and trademarks portfolios (i.e. of their IP bundle) should allow for a better 
understanding of the extent to which top R&D corporate investors introduce technological 
                                                 
36
 See http://www.epo.org/law-practice/legal-texts/epc.html for more information about the EPC. 
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and non-technological (e.g.  organisational, marketing, services) innovations onto the market 
and about their strategic behaviours.  
Figure 5.1 and Figure 5.2 illustrate the use that world top R&D investors make of patents 
and trademarks, of trademarks only, of patents only or of none of the two IPR types. Data 
relate to the USPTO, the EPO and OHIM, and the JPO, and are displayed by headquarters 
location (Figure 5.1) and by industry (Figure 5.2).  
As Figure 5.1 shows, the overall shares of the different IP strategies that companies 
pursue vary greatly, depending on the IP office considered and the location of the 
headquarters. Differences appear more pronounced when comparing USPTO or EPO/OHIM 
with JPO’s.   
Figure 5.1 –Top R&D investors with trademarks and patents, by companies’ headquarter location, 2010-12  
Share of companies with trademarks and/or patents filed at USPTO, EPO & OHIM, and JPO 
 
Note: Data relate to countries with at least 20 companies in the top 2000 corporate R&D investors sample. Countries are 
ranked according to USPTO figures. 
Source: IPTS-OECD, calculations based on EU R&D Scoreboard data, 2013; the Worldwide Patent Statistical Database, EPO, 
December 2014; and OECD Trademark database (internal), 2014. 
Evidence suggests that patents and trademarks are generally used in a complementary 
fashion rather than as substitutes, at least at the USPTO and the EPO/OHIM. Such a dual 
strategy is clearly preferred by top R&D performers headquartered in almost all countries 
(overall nearly 70% at the USPTO and 56% at the EPO/OHIM jointly use the two types of 
IPR). China-headquartered R&D investors (the majority of which use neither patents nor 
trademarks), and Korea-headquartered top corporate R&D investors activities at the 
EPO/OHIM represent exceptions in this respect.  
Companies headquartered in the United-States, France, Switzerland, Denmark, Finland, 
Germany, Japan and the Netherlands jointly use the two intellectual property rights at levels 
that are above the overall sample average, at both the USPTO and the EPO/OHIM. Within 
this first group, companies headquartered in the Netherlands tend to rely relatively more often 
on a trademarks-only strategy at the USPTO and the EPO/OHIM - about 15% of firms, a 
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share that is substantially higher than the others. This is also true for US- and Switzerland-
based companies’ applications, but only at the USPTO. Very low shares of companies opting 
for a Trademarks only strategy at the EU and US offices emerge in relation to Japanese and 
Finnish top corporate R&D investors.   
Companies located in Italy, India, Korea and Sweden also make a fairly high use of 
combined patent and trademark protection (more than 65% of firms at USPTO and more than 
35% at OHIM). Within this group, the share of companies headquartered in Sweden and 
India that filed neither patents nor trademarks in the period analysed is relatively high, 
particularly at the USPTO, as compared to EPO/OHIM figures.  Moreover, India- and Korea-
based top R&D investors show a very high share of Patent only strategies at the EPO/OHIM 
(31% and 42%, respectively), which is also the case for Japan- and Switzerland-
headquartered companies (29% and 28%, respectively). 
In line with what observed in previous parts of this report, the behaviour of companies at 
JPO differs from the one observed at the other offices. The majority of top corporate R&D 
investors headquartered outside Japan seem to rely neither on JPO patents nor on JPO 
trademarks during the period 2010-12. This is particularly true for companies headquartered 
in China, Finland, India, Sweden, the United Kingdom and Denmark, with the “none” 
strategy chosen by more than 50% of companies. This reflects the low propensity of non-
Japanese top R&D investors to file for IP protection at the JPO, and the predominance of 
Japan-based companies in overall JPO filings. Top corporate R&D performers headquartered 
in Japan conversely exhibit a very high reliance on both JPO patents and trademarks.    
Chinese companies emerge as those that on average rely very little on the joint use of 
patents and trademarks (11% at the EPO/OHIM and 14% at the USPTO). Moreover, the 
proportion of China-headquartered top R&D performers that does not file USPTO, 
EPO/OHIM or JPO patents or trademarks is the highest (50% or more) of the whole sample. 
As shown in Figure 5.2, aggregating data at the industry level help shedding further light 
on the IP behaviour of top corporate R&D performers. These specificities may contribute to 
explain the differences found at the country level, as industrial structure does differ across the 
economies considered. Overall, the joint use of patents and trademarks is favoured by most 
industries, although shares appear to significantly vary depending on the industry and the IP 
office considered. The relative preference for Patents only or for Trademarks only strategies 
also differs across industries.  
Coherently with what is observed in Figure 5.1, companies exhibit substantially similar 
behaviours at USPTO and EPO/OHIM, whereas they behave differently at JPO. As observed 
at the country level, at JPO the “none” strategy is much more frequent, and Trademarks only 
strategies appear particularly important for companies operating in industries such as ‘Food 
products’ (about 40% of top corporate R&D investors), ‘Publishing & broadcasting’ and 
‘Finance & insurance’.  
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Figure 5.2 - Top R&D investors with trademarks and patents, by industry, ISIC rev. 4, 2010-12 
Share of companies with trademarks and/or patents filed at USPTO, EPO & OHIM, and JPO 
 
Note: Data relate to industries with at least 20 companies in the top 2000 corporate R&D investors sample. Industries are 
ranked according to the USPTO figures.  
Source: IPTS-OECD, calculations based on EU R&D Scoreboard data, 2013; the Worldwide Patent Statistical Database, EPO, 
December 2014; and OECD Trademark database (internal), 2014. 
A closer look at the USPTO and EPO/OHIM figures shows that top corporate R&D 
investors in ‘Other manufactures’ and ‘Chemicals’ industries report a joint use of patents and 
trademarks higher than 70%, which is above the overall sample’s average. This dual IP 
protection strategy is less frequent in ‘Construction’, ‘Textiles & apparel’, ‘Finance & 
insurance’, ‘IT services’, ‘Publishing & broadcasting’ and ‘Electricity, gas & steam’. The 
latter sector reports higher shares of Patents only strategies, while the former ones tend to 
favour either dual IP strategies or the Trademarks only strategies. Other non-negligible shares 
of Patents only filing behaviours at the USPTO and the EPO/OHIM can be observed in the 
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case of ‘Computers & electronics’, and ‘Scientific R&D’ companies.  
A relatively high proportion of top corporate R&D investors in ‘IT services’ and ‘Finance 
& insurance’, as well as ‘Construction’ and 'Electricity, gas & steam’ industries rely either on 
alternative means of protection or on no IP protection at all.  
Figure 5.3 further explores the IP bundle-related behaviours of the top 2000 corporate 
R&D investors worldwide across industries, in terms of number of patents and trademarks 
applications in the USPTO, EPO-OHIM and JPO, in the years 2010-12. To allow for inter-
industry comparisons, the average number of IPR per company is reported.  
Overall, based on the offices and definitions considered, top corporate R&D investors 
worldwide file a higher number of patents than of TM applications. These patterns would be 
even more pronounced if individual patent applications were to be considered instead of 
patent families. However, the use of the two IP protection means varies widely across 
industries. Generally, top corporate R&D investors show a relatively higher IP activity in US 
market, with the average number of patents and trademarks that is largest at USPTO for more 
than half of the industries. This may relate to the size and attractiveness of the US market for 
both technologies and end-products.    
The ‘Electrical Equipment’ and ‘Computers & electronics’ industries outstand in terms of 
patented inventions per company. Moreover, in these industries the trademark-to-patent ratio 
is among the lowest. ‘Transport equipment’ and ‘Machinery’ show similar ratios and, to a 
lesser extent, a high propensity to patent. In these industries, innovation is seemingly based 
on the development of new technological solutions, likely affecting the different features of 
complex products, rather than on product differentiation.  
Only few industries report trademarks numbers that are higher than patents’ and feature 
low average numbers of patent applications per company. Among them ‘Food products’, 
‘Textiles & apparel’, ‘Wholesale, retail, repairs’ when all offices are considered; and 
‘Pharmaceuticals’ and ‘Other manufactures’ when the focus is on filings at the USPTO and 
the JPO. All these industries indicate a patent propensity below the sample average.  
Finally, top R&D performers operating in the ‘Chemical’ industry display relatively high 
numbers in terms of both trademarks and patents applications. 
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Figure 5.3 - The IP bundle of world Top R&D investors, by industry, ISIC rev. 4, 2010-12 
Average number of trademark and patent applications filed at USPTO, EPO & OHIM, and JPO per company 
 
Note: Data relate to industries with at least 20 companies in the top 2000 corporate R&D investors sample. Industries are 
ranked according to the USPTO figures.  
Source: IPTS-OECD, calculations based on EU R&D Scoreboard data, 2013; the Worldwide Patent Statistical Database, EPO, 
December 2014; and OECD Trademark database (internal), 2014. 
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5.2. Patents and word marks: a look at commonalities across offices 
This section explores the commonalities in terms of patents and word marks of the top 
corporate R&D investors worldwide. As explained in 4.3.2, in principle IP data allow 
tracking applications related to the same technical inventions in the case of patents and to the 
same good(s) and/or service(s) in the case of trademarks. However, priority claims remain 
rarely used in trademark applications, making it difficult to track identical trademarks that are 
filed at different IP offices. Therefore, using trademark priority records would provide a 
partial view on the use of the same trademark in different markets.  
The experimental methodology proposed in Section 4, which relies on word marks, is 
extended here to analyse the exploitation of the same patents and trademarks across 
geographical markets. To this end, information about the extent to which an invention is 
patented by different offices and about the use of the very same word(s) in TM applications 
filed at different offices is used. Such an approach is meant to investigate whether companies 
have similar or differentiated patenting and trademarking strategies in different markets. The 
analysis is restricted to applications made to the USPTO and the EPO/OHIM, for which 
information on patent and word marks is available.  
Figure 5.4 presents the shares of patents and word marks that are common to the US and 
European offices over the total number of patent and word mark applications in the sample. 
Companies are grouped according to the industries they belong to and values are ranked 
according to the shares of EPO-USPTO patent families.  
Figure 5.4 - Joint IP protection in Europe and in the United States, by industry, ISIC rev.4, 2010-12 
Average share of patent families filed simultaneously at EPO and at USPTO in total patent families with EPO and USPTO 
and 
Average share of common OHIM and USPTO word marks in total trademarks filed at OHIM and USPTO 
 
Note: Data relate to industries with at least 20 companies in the top 2000 corporate R&D investors sample. Companies with at 
least 10 EPO-USPTO patent families or 10 OHIM-USPTO word marks are considered in the aggregation. 
Source: IPTS-OECD, calculations based on EU R&D Scoreboard data, 2013; the Worldwide Patent Statistical Database, EPO, 
December 2014 and OECD Trademark database (internal), 2014. 
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The fact that the share of common patents is higher than that of common word marks in 
all industries may signal that top corporate R&D investors likely differentiate their brands or 
products to a greater extent than they do in terms of technologies. ‘Pharmaceuticals’ and 
'Food products’ on the one hand, and ‘Computers & electronics’ and ‘Textiles & apparel’ 
industries on the other hand, delineate quite well the spectrum of combinations. 
‘Pharmaceuticals’ and ‘Food products’ industries show the highest shares of EPO-USPTO 
patent families, and among the lowest shares of common word marks. Conversely, 
‘Computers & electronics’ and ‘Textiles & apparel’ exhibit the lowest shares of common 
patent families, and among the highest shares of common word marks.  
Comparatively high proportions of common word marks in ‘Scientific R&D’ and ‘Other 
manufactures’ industries are associated with important patent activities at both the EPO and 
the USPTO. In addition, it can be noted that the majority of industries with a high average 
number of patents per company, such as ‘Electrical equipment’, ‘Computer & electronics’ 
and ‘Transport equipment’ (see fig. 5.3) own amongst the lowest shares of common EPO-
USPTO patent families. ‘Computers & electronics’, however, stands out because of its share 
of common word marks, which is the highest of the sample. In this industry, the proportion of 
common trademarks and patents looks very similar, possibly reflecting the international 
dimension of both the technology creation space and of end-product markets. 
Figure 5.5 presents the number of common word marks per joint EPO-USPTO patent 
family. With the exception of ‘Textile & apparel’, all industries show lower numbers of 
common word marks than patent applications.  
Figure 5.5 - Common OHIM-USPTO word marks per joint EPO-USPTO family, by industry, ISIC rev.4, 2010-12 
Average number of common OHIM-USPTO word marks over the average number of joint EPO-USPTO families per company 
 
Note: Data relate to industries with at least 20 companies in the top 2000 corporate R&D investors sample. 
Source: IPTS-OECD, calculations based on EU R&D Scoreboard data, 2013; the Worldwide Patent Statistical Database, EPO, 
December 2014 and OECD Trademark database (internal), 2014. 
Industry-specific differences in the ratio common word mark to common patent clearly 
emerge. The most frequent use of common word marks for the ‘Textiles & apparel’ industries 
0.0
0.1
0.2
0.3
0.4
1.0
 World Corporate Top R&D Investors: Innovation and IP bundles 
 
79 
may signal the existence of global strategies in terms of product diversification. 
Most of the industries presenting a high number of common word marks relative to 
common patents are also those with a relatively higher average number of trademarks as 
compared to the average number of patents (see fig 5.3). These include, for instance the 
‘Textiles & apparel’, ‘Pharmaceuticals’, ‘Scientific R&D’, ‘Food products’ and ‘Other 
manufactures’ industries. 
5.3. Using trademarks as a complement to patent protection  
Patents, and the technological developments that companies protect through them, are 
often accompanied by trademarks aimed at differentiating goods on the market and at 
signalling their existence to prospect consumers. As the same technology may lead to various 
commercial applications it is interesting to look at the association between technology classes 
and product fields, and verify the extent to which different technologies relate to different 
product classes. 
Figure 5.6 shows the composition in terms of Nice classes of the trademark portfolios of 
top corporate R&D investors owning patent families. Data are shown by the technology field 
in which patents are applied and calculations rely on patent and trademark data from 
EPO/OHIM, JPO and USPTO taken together. Only the top four trademark classes are 
reported. Similar indicators constructed at the level of each office are presented in Appendix 
3.  
Figure 5.6 – Composition of patenting companies’ trademark portfolio, 2010-12 
Top 4 trademark classes associated with patented technologies 
 
Source: IPTS-OECD, calculations based on EU R&D Scoreboard data, 2013; the Worldwide Patent Statistical Database, EPO, 
December 2014 and OECD Trademark database (internal), 2014. 
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also filed at least one TM application at any of the three offices over the period 2010-12. 
Coherently with the statistics presented so far, the propensity to use trademarks along with 
patents appears to vary depending on the technological domain in which patenting companies 
are active.  
Also, by looking at the combinations of product classes per technology, a number of 
patterns emerge. As reflected by the overall distribution of good-related trademark classes 
discussed in Section 4, Instruments and computers (class 9) and/or Pharmaceuticals products 
(class 5) are the most frequently designated classes in TM applications. Instruments and 
computers does indeed rank among the top four trademark classes protected by top R&D 
investors worldwide, and independently of the specific technologies covered by their patents. 
Companies with patents in Basic or Digital communication, or Telecommunications, 
registered 40% of their TM in Instruments and computers class. Two additional classes, 
among the most frequent, include Machineries (class 7) and Chemicals goods (class 1), 
although they appear in much lower proportions than the top two classes. Machineries further 
stands out as a class designated in a broad range of technological domains (at least once in 28 
out of the 35 technology fields).  
Patented technologies related to Pharmaceuticals, Bio materials and Biotechnology, 
Chemistry (Organic, Basic or Food Chemistry) and Polymers, are frequently associated with 
TM applications in Chemical goods (class 1) and Pharmaceutical products (class 5). 
Furthermore Vehicles (class 12), representing a non-negligible share of trademarks 
applications, also shows some sort of ‘horizontal’ nature, as it is designated in about one-third 
of the technology classes.  
A closer look at TM services classes points out again the relative importance of R&D and 
software (class 42) for a broad range of technologies. More limited, are the frequencies of 
Telecommunications (class 38) and Business and advertising (class 35), which is designated 
only in association with Digital communication, Telecommunications, IT methods and 
Computer technology.  
The patterns observed mirror the substantial homogeneity of behaviours that can be 
observed when IP offices are considered in a separate fashion, as done in Appendix 3. The 
main noticeable differences across offices concern the extent to which patenting companies 
rely on trademarks.  
The share of companies patenting at EPO that do not register trademarks at OHIM ranges 
between 20% and 40% across technology fields, whereas this share is always lower than 12% 
for USPTO, and above 40% for JPO. Also, the shares of the top 3 TM classes across patented 
technologies vary between 30% and 55% at the USPTO, 36% and 80% at the EPO/OHIM 
and between 37% and 75% at the JPO.  
The three figures in Appendix 3 confirm the prominence of Instruments and computers 
(class 9) and/or Pharmaceuticals products (class 5), although percentages differ greatly 
across technologies and offices. In addition, Machineries (class 7) also shows up among the 
classes used in conjunction with a broad range of technologies when offices are considered 
separately. Similarly, but for a narrower set of patented technologies, Vehicles (class 12) and 
Chemicals goods (class 1) (also Medical Instruments at the JPO), appear among the most 
designated TM classes in the offices considered.  
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Depending on the industry they belong to, top corporate R&D investors seemingly tend 
to combine different patented technologies with different trademark classes. Figure 5.7 
proposes a disaggregation of the patent-and-trademark combinations at the industry level. 
The x-axis reports the technology fields of companies’ patent portfolios, and the y-axis 
presents the product classes designated in their TM applications. The circles indicate the most 
frequent combinations of technology and product classes observed in the IP bundle by 
industry. The size of the circles denotes the number of companies featuring these 
combinations, and the percentage points denote the proportion that these companies represent 
of the industry they belong to.  
Figure 5.7 – Composition of the IP portfolio of companies, by industry, ISIC rev. 4, 2010-12 
Most frequent combinations of the top patented classes and top trademark classes by company 
  
Note: Data relate to industries with at least 20 companies in the top 2000 corporate R&D investors sample. The most frequent 
combinations of patent and TM classes are identified as the aggregation of the most patented technology with the most 
trademarked class in a given company’s IP portfolio. The size of the bubbles denotes the number of companies featuring this 
combination and the percentage points denote the proportion that these companies represent of the industry they belong to.  
Source: IPTS-OECD, calculations based on EU R&D Scoreboard data, 2013; the Worldwide Patent Statistical Database, EPO, 
December 2014 and OECD Trademark database (internal), 2014. 
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show a high share of companies concentrated around related IPs. In ‘Pharmaceuticals’ and 
‘Scientific R&D’ industries, more than 50% and one-third of companies (respectively), 
feature an IP portfolio mainly composed of patents in Pharmaceuticals and trademarks in 
Pharmaceutical products. The combination of Computer technology and Instruments & 
Computers is most frequent for the following industries: ‘Computers & electronics’, ‘IT 
services’ and ‘Publishing & broadcasting’. However, the relative importance of this 
combination varies, with values of around 12% of companies in the former two industries and 
23% in the latter.  
More than one-fifth of companies operating in the ‘Food products’ industry relies 
predominantly on patents relating to Food chemistry and trademarks related to Condiments 
and cereals. A similar pattern is observed for the bigger group of companies in the ‘Transport 
equipment’ industry, relying on Transport-related technologies and the Vehicles class. The 
same holds also true for much smaller groups of companies from industries such as 
‘Telecommunications’ (relying on Digital communication and on Instruments and computers 
– class 9) and ‘Electrical equipment’ (Electrical machinery and Instruments and computers – 
class 9). 
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Conclusion 
This report, result of a collaborative project between the EC-JRC and the OECD 
Directorate for Science, Technology and Innovation, sheds some light on the extent to which 
the innovative efforts of the top R&D corporate investors worldwide result in the 
development of new technologies and the launch of new products on global markets.  
The wealth of indicators contained in, and dataset associated with, this joint report 
provide evidence in support of policy making by characterising the link between R&D 
spending, technological developments, and the launch of new products and processes. It 
further provides insights about the different strategies that top corporate R&D investors 
worldwide pursue, and about the existence of industry- and country-specific patterns. As top 
corporate R&D investors worldwide are at the technology frontier and account for a 
substantial amount of innovation-related investment and output, understanding and 
monitoring their behaviours might enhance policy makers’ ability to design policies aimed at 
fostering innovation, productivity and, ultimately, more and better jobs.  
The evidence proposed in this report suggests that top corporate R&D investors, who own 
66% of all IP5 patent families worldwide, display a wide heterogeneity in their propensity to 
patent but concentrate their patent filings in a relatively narrow set of technologies, especially 
related to electrical and mechanical engineering. Also, over the last ten years, inventions 
related to ICTs have increased, whereas those related to pharmaceuticals have declined in 
relative terms. 
The important and growing role of Asia for technological developments further emerges: 
of the top ten patenting companies in the sample nine are headquartered in Asia and eight 
belong to the ICT sector. Overall, these ten top corporate R&D performers account for one 
fourth of all the patents owned by these R&D investors.   
Analysis based on the location and industrial activity of both headquarters and affiliate 
companies suggests that geographical and technological patterns are positively correlated, 
and that the degree of technological specialisation varies widely across industries. Companies 
that have a highly diversified corporate structure - in terms of industries to which their 
affiliates belong – appear also technologically diversified. Technological diversification 
further relates to geographical diversification (i.e. to the extent to which subsidiaries are 
located in countries other than the one of the headquarters), but to a less extent.  
Top corporate R&D investors located in Europe and the United States appear relatively 
more specialised in a wider array of technologies, including those that are fundamental to 
address grand challenges such as health, ageing and the environment. Korean, Chinese and 
Japanese based companies show a high specialisation in ICT-related technologies whereas 
European-based ones show lower technological advantages in this field. Japanese based 
companies appear to be specialised in a wider array of technologies than Korean and Chinese 
ones.  
Markets do matter, and top corporate R&D investors pursue distinct patent filings 
strategies across IP offices and over time, with the current picture that reflects the rapid 
increases of filings at the Korean and Chinese offices. Filing strategies across the IP5 offices 
appear to further depend upon the technological field of the invention to protect. Patent 
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families filed at the USPTO, the KIPO, and the SIPO are largely oriented towards Electrical 
engineering, while EPO patent families show a stronger orientation towards Mechanical 
engineering and Chemistry. Patent families at the JPO are the most oriented towards 
Instruments and to a lesser extent towards Mechanical engineering.  
In terms of the technological and economic value of patents, indicators further suggest 
that applications at the USPTO are generally protected in a relatively smaller number of 
countries, i.e. are of smaller family size, fact which might reflect the attractiveness of the US 
market vis-à-vis other markets. These patent families are comparatively narrower in 
technological scope with respect to the EPO ones, but exhibit a higher radicalness.  
Top corporate R&D investors appear to importantly rely on international knowledge to 
develop their technologies, as about one fourth of companies’ patent portfolios have been 
developed by teams of inventors residing in countries that are different from the location of 
the headquarters. For companies operating in ‘Mining’, ‘Finance & insurance’ and 
‘Pharmaceutical’ industries patents featuring an international team of inventors correspond to 
more than half of the portfolios. These dynamics underline the importance of knowledge 
repositories and skills in driving inventive activities and shaping global value chains. 
Target markets and home markets, i.e. the country of the headquarters, do matter also in 
the case of trademarking strategies. Trademarks are mostly filed by top corporate R&D 
investors headquartered in the United States, Japan, Germany, the United Kingdom and 
France; companies tend to be more active at the USPTO than at the OHIM. JPO is the office 
presenting the highest home specificity, as more than three quarters of patent applications 
come from Japan headquartered companies.  
TM applications also exhibit significant industrial specificities in terms of number of 
trademarks, trademark intensity (i.e. number of trademarks per Euro of net sales) and 
concentration ratios. They are further concentrated in few classes and products fields, and 
mostly refer to goods or to goods and services jointly, especially in Instruments and 
computers and Pharmaceutical products. Services-related trademarks pertain mainly to R&D 
and software, with knowledge based assets-related trademarks reflecting applications from a 
narrow set of countries featuring developed and competitive markets for research. Top 
corporate R&D investors from China and Korea exhibit a strong orientation towards ICT and 
audiovisuals related trademarks.  
Overall, top corporate R&D investors use patents and trademarks as complementary 
protection means, and the combined use of these IPRs is favoured by the majority of 
companies in the US and European markets. Companies from ‘Chemicals’, 
‘Pharmaceuticals’, ‘Food products’, ‘Computers & electronics’ industries are keen on 
combining the two types of IPRs, whereas services-oriented companies operating in the ‘IT 
services’ and ‘Finance & insurance’ industries tend to protect their assets primarily through 
trademarks. All-in-all patents still constitute the most commonly used means of protection at 
the USPTO, the EPO/OHIM and the JPO, while firms in industries with low patent 
propensities as ‘Food products’ and ‘Pharmaceuticals’ tend to have more TM applications.  
In terms of technological and product differentiation, the indicators proposed in this 
report suggest that top corporate R&D investors more frequently pursue identical 
technological strategies than identical branding ones. Moreover, a negative correlation can be 
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generally observed between technological and branding strategies, whereby companies in 
industries featuring high proportions of common patents exhibit low shares of identical word 
trademarks, and industries with the lowest shares of common patents (e.g. ‘Computers & 
electronics’ and ‘Textiles & apparel’), are more likely to employ the same word in trademark 
applications filed at different offices.  
Analysing the IP bundle and the extent to which technology areas align with the products’ 
space a clear pattern emerges: few companies present technology/product combinations in 
line with the profile of the industry in which they operate. Also, the horizontality of R&D and 
software emerges, as TMs related to R&D and software are owned by companies having very 
different technological profiles. The ‘Pharmaceutical’ industry shows the strongest 
uniformity, with more than half of its companies featuring an IP portfolio mainly composed 
of patents in Pharmaceuticals and trademarks in Pharmaceutical products. 
The stylised facts above represent a small proportion of the wealth of information that can 
be extracted from the dataset constructed for the analysis. This is why the EC-JRC and the 
OECD have decided to put these data in the public domain, hoping that researchers, analysts 
and all those interested would use them in statistical and econometric analyses to generate 
evidence in support of policy making. Understanding the role of top players in shaping 
technology developments and their positioning on global knowledge networks is key to 
innovation policy making in today’s globalised world. 
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Appendices 
Appendix 1:  
Distribution of TM applications per company, by industry, ISIC rev. 4, 2010-12 
 
Source: IPTS-OECD, calculations based on EU R&D Scoreboard data, 2013; and OECD Trademark database (internal), 2014. 
 
  
Mean Median P25 P75 Mean Median P25 P75 Mean Median P25 P75 Mean Median P25 P75
Law, accountancy & engineering 14.1 6.5 1.0 22.5 24.8 6.5 1.0 23.5 0.4 0.0 0.0 0.0 6.5 1.0 0.0 5.5
Wholesale, retail, repairs 24.2 5.0 1.0 34.0 15.3 4.0 0.0 22.0 25.1 0.0 0.0 4.0 3.0 1.0 0.0 4.0
Mining 14.7 5.0 0.0 11.0 7.6 1.0 0.0 7.0 3.7 0.0 0.0 0.0 3.5 1.0 0.0 5.0
Wood & paper 26.4 14.0 2.0 44.0 14.1 2.5 0.0 21.0 27.6 0.0 0.0 21.0 7.3 1.0 0.0 7.5
Electricity, gas & steam 9.8 0.0 0.0 6.5 7.1 1.0 0.0 11.0 7.8 0.0 0.0 2.5 1.1 0.0 0.0 0.0
Machinery 19.2 6.0 2.0 20.0 9.9 3.0 0.0 10.0 10.9 1.0 0.0 8.0 4.5 1.0 0.0 4.0
Transport equipment 22.8 4.0 1.0 21.0 14.0 2.0 0.0 13.5 12.8 0.0 0.0 6.5 6.1 1.0 0.0 3.5
Chemicals 50.5 16.0 5.0 48.0 28.9 7.0 0.0 24.0 61.0 7.0 0.0 50.0 12.7 3.0 0.0 10.0
Telecommunications 24.7 4.5 1.0 27.0 16.8 2.0 0.0 8.5 23.6 0.0 0.0 1.0 4.6 0.0 0.0 4.5
Basic metals 11.7 5.0 0.0 15.5 6.0 1.0 0.0 7.0 12.9 0.0 0.0 3.0 2.6 1.0 0.0 3.0
Construction 6.2 1.0 0.0 9.0 7.0 0.0 0.0 3.0 29.0 0.0 0.0 57.0 2.7 0.0 0.0 4.0
Rubber, plastics, minerals 23.7 8.0 1.0 21.0 16.1 3.5 0.0 11.0 22.8 1.0 0.0 24.0 6.4 1.0 0.0 6.0
Finance & insurance 23.7 5.0 1.0 22.0 16.9 5.0 1.0 21.0 11.1 0.0 0.0 2.0 5.7 1.0 0.0 7.0
Electrical equipment 40.8 6.0 1.0 49.0 23.8 4.0 0.0 22.0 45.0 0.0 0.0 14.0 9.1 1.0 0.0 6.0
Publishing & broadcasting 19.4 10.0 3.0 20.0 7.5 2.0 0.0 7.0 3.7 0.0 0.0 2.0 3.2 1.0 0.0 3.0
Food products 69.9 21.0 6.0 78.0 27.0 9.0 1.0 26.0 94.1 9.0 2.0 96.0 16.4 2.0 0.0 14.0
Other manufactures 86.9 25.0 12.0 77.0 26.5 14.0 6.0 34.0 55.6 3.0 0.0 18.0 12.5 5.0 0.0 15.0
IT services 18.5 6.0 1.0 16.0 4.7 2.0 0.0 5.0 4.0 0.0 0.0 1.0 2.9 0.0 0.0 2.0
Textiles & apparel 31.3 3.0 0.0 13.0 11.9 0.0 0.0 8.0 48.9 3.5 0.0 42.0 8.3 1.0 0.0 2.0
Computers & electronics 21.9 6.0 1.0 19.0 11.3 2.0 0.0 8.0 13.2 0.0 0.0 4.0 4.4 0.0 0.0 2.0
Pharmaceuticals 65.3 6.5 1.0 34.0 28.1 2.0 0.0 27.0 35.8 0.0 0.0 17.0 14.6 0.5 0.0 8.0
Scientific R&D 15.2 7.0 2.0 22.0 4.5 1.0 0.0 4.0 5.1 0.0 0.0 1.0 4.5 1.0 0.0 4.0
All firms 30.3 7.0 1.0 23.5 14.9 2.0 0.0 13.0 22.7 0.0 0.0 7.0 6.6 1.0 0.0 4.0
OHIM JPO IP AUS
Number of applications per company
USPTO
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Appendix 2:  
Distribution of TM applications at IP AUS by Nice class,  
by companies’ headquarter location, 2010-12 
 
Note: Trademark counts by international classes are based on the application date and the location of the applicant’s 
headquarters, using fractional counts. Blue bars and percentages correspond to the distribution of Nice classes in the 
trademark applications of the region considered. Only percentages higher than 1% are displayed. Grey cells correspond to 
classes with no applications from the region/office considered. 
Source: IPTS-OECD, calculations based on EU R&D Scoreboard data, 2013; and OECD Trademark database (internal), 2014. 
  
USA EU28 JPN KOR CHN RoW
1-Chemical goods 3.6 5.1 3.4 0.5 0.2 4.4
2-Paints and colorants 1.2 0.9 0.9 0.0 0.0 0.2
3-Cleaning products 6.7 9.9 2.8 0.1 0.8 1.7
4-Oils and fuels 0.4 0.9 0.2 0.3 3.0 0.3
5-Pharma products 13.0 20.6 14.5 0.1 1.3 24.2
6-Metals 1.3 1.3 0.9 0.4 2.4 1.5
7-Machineries 2.4 3.9 5.0 4.7 17.3 2.6
8-Hand tools 0.6 0.6 0.1 0.0 4.0 0.4
9-Instruments & computers 20.4 11.5 19.5 59.0 26.8 15.4
10-Medical instruments 9.0 6.3 2.3 0.3 0.0 5.1
11-Lightening and heating 1.6 2.5 1.9 11.4 2.9 2.2
12-Vehicles 2.0 5.3 8.7 11.9 19.0 0.8
13-Firearms 0.5 0.1 0.0 0.0 0.0 0.1
14-Precious goods 0.1 0.4 0.4 0.0 0.0 5.1
15-Musical instruments 0.0 0.0 0.3 0.0 0.0 0.0
16-Papers and packaging 2.1 1.6 1.7 0.0 0.4 2.1
17-Rubber and plastics 1.0 1.7 1.3 0.4 0.4 1.1
18-Leather and complements 0.2 0.5 0.1 0.2 0.4 0.3
19-Building material 0.4 1.5 0.3 0.7 1.2 0.7
20-Furniture 0.9 0.3 0.3 0.0 0.3 0.3
21-House utensils 0.9 1.1 0.5 0.0 0.8 0.5
22-Fibrous products 0.2 0.1 0.1 0.0 0.0 0.0
23-Yarns and threads 0.0 0.1 0.1 0.0 0.0 0.0
24-Textiles 0.2 0.3 0.1 0.0 0.0 0.1
25-Clothing and footwear 0.8 1.2 1.1 0.0 0.7 0.3
26-Decorations 0.0 0.1 0.2 0.0 0.3 0.0
27-Carpets and floor covers 0.0 0.2 0.1 0.2 0.3 0.1
28-Games 4.9 1.2 6.2 0.2 0.9 0.5
29-Food 1.4 0.8 2.1 0.4 0.0 2.2
30-Condiments and cereals 3.3 1.3 1.1 0.2 0.7 3.9
31-Animals and grains 0.3 0.6 0.6 0.0 0.0 0.8
32-Low and non alcohol drinks 0.3 0.5 6.0 0.0 0.0 0.6
33-Alcoholic drinks 0.0 1.5 4.7 0.0 0.0 0.0
34-Tobaccos 3.2 0.7 0.7 0.9 0.1 0.0
35-Business and advertising 2.8 2.4 2.3 1.8 1.4 4.0
36-Insurance and finance 0.8 1.3 0.9 0.4 0.7 5.6
37-Building services 1.1 1.9 1.8 1.5 10.3 0.9
38-Telecommunications 1.0 1.3 0.6 1.3 0.3 1.4
39-Transport and packaging 0.3 0.7 0.1 0.5 1.2 0.3
40-Treatment of materials 0.4 0.7 0.4 0.1 0.0 0.8
41-Education and sport 2.9 2.0 2.3 1.3 0.4 3.8
42-R&D and software 5.7 3.6 3.0 1.1 1.5 2.9
43-Food, drink and accommodation 0.3 0.2 0.3 0.0 0.0 0.4
44-Medical and hygiene services 1.0 1.0 0.2 0.1 0.0 2.1
45-Legal and personal services 0.7 0.3 0.2 0.0 0.1 0.3
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Appendix 3:  
Composition of patenting companies’ trademark portfolio, 2010-12 
A3.1 Top 4 trademark classes associated with patented technologies, USPTO 
 
A3.2 Top 4 trademark classes associated with patented technologies, EPO & OHIM 
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A3.3 Top 4 trademark classes associated with patented technologies, JPO 
 
Source: IPTS-OECD, calculations based on EU R&D Scoreboard data, 2013; the Worldwide Patent Statistical Database, EPO, 
December 2014 and OECD Trademark database (internal), 2014. 
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